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The ultimate goal of the present study is to aid in the development of tools to assist in the 
treatment of cardiovascular disease.  Gaining an understanding of hemodynamic parameters for 
medical implants allow clinicians to have some patient-specific proposals for intervention 
planning.  In the present study a full cardiovascular experimental phantom and digital phantom 
(CFD model) was fabricated to study: (1) the effects of local hemodynamics on global 
hemodynamics, (2) the effects of transition from bed-rest to upright position, and (3) transport of 
dye (drug delivery) in the arterial system.  Computational three dimensional (3-D) models 
(designs A, B, and C) stents were also developed to study the effects of stent design on 
hemodynamic flow and the effects of drug deposition into the arterial wall.  The experimental 
phantom used in the present study is the first system reported in literature to be used for 
hemodynamic assessment in static and orthostatic posture changes.  Both the digital and 
experimental phantom proved to provide different magnitudes of wall shear and normal stresses 
in sections where previous studies have only analyzed single arteries.   
The dye mass concentration study for the digital and experimental cardiovascular 
phantom proved to be useful as a surrogate for medical drug dispersion.   The dye mass 
concentration provided information such as transition time and drug trajectory paths.  For the 
stent design CFD studies, hemodynamic results (wall shear stress (WSS), normal stress, and 
vorticity) were assessed to determine if simplified stented geometries can be used as a surrogate 
for patient-specific geometries and the role of stent design on flow.  Substantial differences in 
hemodynamic parameters were found to exist which confirms the need for patient-specific 
modeling.  For drug eluting stent studies, the total deposition time for the drug into the arterial 




1 CHAPTER 1 
Introduction 
 
Cardiovascular disease (CVD) remains to be the prominent cause of morbidity and 
mortality across the world and improved methods for cardiovascular disease management are 
deeply needed (Ricotta, Pagan et al. 2008).  In the year 2000, cardiovascular disease accounted 
for 39% of all deaths in America, and 32.4% in 2006, producing a health care cost of $430 
billion per year (Daviglus 2005, Kung 2005, Murray 2006, Rosamond, Flegal et al. 2007).  The 
most common form of cardiovascular disease is coronary heart disease (CHD), also referred to as 
atherosclerosis.  Atherosclerosis is a disorder in which fatty deposits develop in an artery, 
obstruct the lumen, and cause deformation and deterioration of the arterial wall.  Critical 
conditions arise when atherosclerosis occurs in the coronary arteries and threatens to reduce 
blood flow to the myocardium.  The reduction of blood flow to the heart forces the heart to 
produce more work and undergo stress, which eventually leads to heart failure.  The result of 
reduced blood flow and stress to the heart is angina pectoris (chest pain) or myocardial infarction 
(heart attack).  Also, the reduction of oxygen-rich blood to the brain results in brain cell death 
(stroke). 
The carotid bifurcation, where the common carotid artery (CCA) branches into the 
internal carotid artery (ICA) and external carotid artery (ECA) is a common site of 
atherosclerotic disease (Hewlin and Kizito 2011).  Stenosis or narrowing of the ICA has long 
been known to be related to the incidence of ischemic stroke (Barnette et al. 200; Fisher 1951).  
In severe atherosclerosis, plaque buildup significantly reduces the internal dimensions of the 




nature, and is composed of fats, proteins, and regions of calcification separated by a thin layer 
called the “fibrous cap”.  The streaked appearance of the histology clearly highlights the 
heterogeneity of the plaque.  This extreme heterogeneity coupled with the highly irregular shape 
of the lumen makes it difficult to predict the mechanical behavior of the plaque as a response to 
WSS and normal stresses (NS).  In healthy arteries, there is evidence to suggest that the arterial 
system remodels to maintain wall shear stress (WSS) within a narrow range of 1-2 Pa. 
 
                    
Figure 1.1. Cross-section through an atherosclerotic carotid artery.  Obtained from (Bale-
Glickman, Selby et al. 2003). 
 
Consequently, the use of modeling stenosis severity or degree of constriction has evolved 
as a surrogate to measure the risk of stroke.  Mechanical properties of the arterial walls are 
significantly altered by atherosclerosis.  The interaction between flowing blood and the artery 
wall is important in studying the development and progression of arterial disease and risk of 
stroke (Ku, Giddens et al. 1985, Ku 1997).  Since the ICA supplies blood to the brain, plaque 




in the ECA.  A magnetic resonance angiogram of a healthy and stenosed carotid bifurcation 
artery is provided in Figure 1.2.  The next section presents a discussion on the motivation of the 
present study. 
 
                               
Figure 1.2. Magnetic resonance angiograms of (a) a healthy carotid bifurcation, (b) an 
atherosclerotic carotid bifurcation.  CCA-common carotid artery; ECA-external 
carotid artery; ICA-internal carotid artery.  Obtained from (Bale-Glickman, Selby 
et al. 2003). 
 
1.1 Motivation of the Present Study  
Although there has been more than thirty years of cardiovascular research, the fluid 
dynamics of arteries are still poorly misunderstood (Zhang, Agnoletti et al. 2014).  Fluid 
dynamics is a subject of paramount importance due to the conventional relationship between the 
hemodynamics, endothelial cell response, and vascular pathology (McDonald 1974; Fung 1993).  
Physiological fluid flow is proclaimed to be laminar and organized.  In contrast, diseased 




separating or stagnating flow.  However, understanding and probing the fluid dynamics of 
physiological systems in vivo is exceptionally challenging.  Simplifications and idealizations are 
necessary in order to study the flow phenomena under controlled in vitro experiments.  
Nonetheless, even under these conditions the challenges are massive. 
Complex flow patterns and fluid-structure interactions (FSI) emerge within short, curved, 
branching, elastic tubes that undergo dynamic motions while interacting with propagating and 
reflecting pressure waves (Pedley 2000).  The pressure driven flow is considered to be transient, 
transitional, anisotropic, and inhomogeneous, and is dependent on the frequency and phase of the 
driving pressure.  Entrance effects, unsteady separation, and formation of secondary vortices are 
also prominent.  Comprehensive investigations of such complex flows are hindered by 
limitations of current experimental and computational tools.  Prediction of vascular disease or 
design of effective prosthetic devices cannot be done without a fundamental understanding of the 
physical phenomena that lead to pathological flow conditions. 
A key example of fundamental deficiencies is the use of vascular stents, particularly in 
coronary arteries, where flow dynamics are further complicated due to a flow and pressure phase 
offset and dynamic curvature changes.  Stents are a class of cardiovascular implants used to re-
open arteries and re-new normalized blood flow.  A stent is a cylindrical tube shaped medical 
tool used for invasive therapy to treat stenosis that has developed inside a blood vessel resulting 
from arteriosclerosis obliterans or other causes.  The overall procedure is nominally invasive and 
clinical studies indicate superior long term patency versus other methods.  As a result, stents 





Millions of stent implant procedures are performed each year.  The use of stents has 
dramatically increased since their approval by the United States Food and Drug Administration 
in 1994, largely because of therapeutic and technological advances.  In 1998 over 800,000 stents 
were implanted in more than 500,000 patients in the United States (Topol 1998).  Recent 
advances in materials, fabrication procedures, and new drug coatings open possibilities for the 
use of stents beyond treatment of stenosed arteries.  For example, stents can be employed for 
treatment of aneurysms or as vehicles for targeted drug delivery.  However, despite their 
widespread use and numerous clinical studies, stents are implanted into arteries without a-priori 
understanding of the associated fluid dynamics.  The positioning of stent struts in the bifurcation 
and the stresses generated in the stent and vessel wall are worthy of investigation for a better 
understanding of the mechanical behavior of artery wall. 
Few experimental investigations into the hemodynamics of stented arteries exist, due to 
many reasons that made computational studies difficult (Duraiswamy, Schoephoerster et al. 
2007; Lewis 2008; Charonko, Karri et al. 2010).  Also, despite extensive previous work there is 
practically no research on the effect that compliance variation and discontinuities have on the 
hydrodynamics (Selvarasu, Tafti et al. 2011; Shuib, Hoskins et al. 2011).  Moreover, although 
healthy physiological flow is primarily laminar and organized, in contrast, diseased conditions, 
namely inflammation, atherogenisis, or thrombus formation, are linked to complex and 
transitional flow that is attributed to localized changes of the geometry and the mechanical 
properties (McDonald 1974; Fung 1993; Batchelor 2002; Selvarasu, Tafti et al. 2011).  One 
difficulty for experimental studies is matching the physical scaling of the small coronary vessels, 




sufficient spatial resolution and accuracy at a 1:1 scale is challenging (Charonko, Karri et al. 
2010). 
Previous studies have overcome some difficulties in working with compliant models by 
using dye visualization in large-scale models (Berry, Santamarina et al. 2000), or performing 
quantitative measurements in idealized, scaled-up, rigid fixtures (Natarajan and Mokhtarzadeh-
Dehghan 2000; Benard, Coisne et al. 2003).  Many studies have used idealized velocity profiles, 
and none took into account the effect of phase angle between the pressure and flow, which 
occurs in the coronary arteries (Qiu and Tarbell 2000).  Also, previous studies have been 
subjected to several assumptions, simplifications, and limitations.  Some studies have neglected 
the effect of the stent deployment strategy and the post-stent injury causes to the artery that 
would contribute to restenosis (Selvarasu, Tafti et al. 2011).  The effect of changes in mechanical 
stresses in the vessel wall might be important and affect vessel remodeling (Selvarasu, Tafti et al. 
2011).  Although, this effect is compounded by the combined hemodynamic changes, and 
literature suggesting that changes in hemodynamics would affect stenosis is extensive.  Yet, if 
and how compliance mismatch affects the local hemodynamics is unresolved.  The next section 
presents the ultimate goal and specific objectives of the present study. 
1.2 Ultimate Goal and Specific Objectives 
The challenges associated with resolving physiological flows include: understanding the 
fundamental physics of physiological flows; understanding the source of disease processes and 
their relation to fluid flow and transport processes; developing novel and improved disease 
diagnostics, treatment methods and implantable devices; and developing biologically-inspired 




development of tools to assist in the treatment of CVD and atherosclerosis.  Gaining an 
understanding of hemodynamic parameters for medical implants allow clinicians to have some 
patient-specific proposals for intervention planning.  By enhancing technical knowledge in this 
area of cardiovascular research, the present study incorporates experimental and computational 
models which include supplementary “non-idealized” features and parameters than previous 
studies have.  The next section presents the specific objectives.  The specific objectives are 
denoted “Obj” and sub-objectives “Sub-obj”.  The subtasks of each sub-objective are bulleted. 
 
(Obj 1.) Develop an arterial cardiovascular experimental phantom to determine the effect of 
orthostatic hypotension on hemodynamic parameters. 
(Sub-Obj 1.) Design and fabricate a cardiovascular experimental phantom that contains 
the aorta, major arteries, and the veins and capillaries mimicked with a resistor. 
 Design a pulse duplicator that can duplicate physiological conditions (pressure, 
flow rate, frequency, and temperature). 
 Instrument the cardiovascular experimental phantom with pressure and flow 
measuring devices. 
 Determine a test protocol for evaluating the cardiovascular phantom in transient 
studies. 
 Obtain physiological data (flow rate, pressure, normal stress, wall shear stress, 
and vorticity) during transition from bed-rest to upright position. 






(Sub Obj 2.) Develop and design a digital cardiovascular phantom for transient studies.  
 Obtain physiological data (flow rate, pressure, normal stress, wall shear stress, 
and vorticity) during transition from bed-rest to upright position. 
 Determine the effect of physiological Peclet numbers on mass transport in the 
phantom. 
(Obj. 2.) Develop methods to model patient-specific arterial geometries to predict hemodynamic 
forces on arterial grafts and implants.   
 Develop a code to import patient-specific CTA scans and create numerical arterial 
core geometries. 
 Use particle imaging velocimetry (PIV) to analyze the flow field. 
 Determine the overall forces that act on implants. 
 Determine the effect of stent design on hemodynamic forces. 
Chapter 2 provides a review of literature on past and current work in the area of 
experimental and computational cardiovascular hemodynamics, stent technology, and drug 
eluting stent analyses.  Chapter 2 characterizes the gaps in knowledge of the review of literature.  
Chapter 3 addresses the methods and materials of the present study.  In Chapter 3, each of the 
measuring tools and devices used in addition to calibration methods and computational 
methodologies are addressed.  Chapter 4 addresses the results of the present study.  Chapter 5 




2 CHAPTER 2  
Literature Review 
 
Chapter 2 provides a review of literature on past and present work in the area of 
cardiovascular disease and hemodynamics.  Experimental and computational models that were 
developed and used by several research groups to simulate the functional behavior of arteries 
under normal and diseased conditions are discussed.  The overall goal of experimental and 
computational modeling is to develop patient-specific predictive models which aim to assist in 
the improvement of: cardiovascular diagnosis, therapy planning and treatment of cardiovascular 
diseases (Menasche 2010; Siebes and Ventikos 2010).  However, the achievement of this goal is 
underpinned by the characterization of the underlying physiological mechanisms derived from 
solid mechanics and fluid mechanics.  The following sections outline the current state of 
knowledge in the area of hemodynamics, both computational and experimental, and categorize 
the questions left unanswered.  The next section will provide an introduction of the pathogenesis 
of atherosclerosis. 
2.1 Cause and Pathogenesis of Atherosclerosis 
Atherosclerosis is defined as a vascular system disease that hardens and narrows the 
arteries.  The disease typically does not become symptomatic until there has been significant 
disease progression.  The set phase for atherosclerosis is when the endothelium of a blood vessel 
is damaged by hypertension, viral infection, diabetes mellitus, or other causes.  Monocyctes 
adhere to the damaged endothelium which results in penetration of endothelium layers and 
transformation into macrophages.  Macrophages and smooth muscle cells absorb cholesterol and 




are visible as a fatty streak on the blood vessel wall.  Platelets also adhere to areas of the 
damaged endothelium sites, de-granulate, and release platelet-derived growth factor (PDGF).  
PDGF stimulates mitosis of smooth muscle which eventually leads to a mass of lipid, smooth 
muscle, and macrophages called atheroma (atherosclerotic plaque).  The muscular and elastic 
tissue of the artery becomes increasingly replaced with scar tissue.  When atheroma becomes 
calcified, it becomes very dense plaque.  Such plaque formation results in arterial rigidity termed 
arteriosclerosis. 
There are several surgical techniques that are used to treat atherosclerotic symptomatic 
patients.  However, these treatments require precise knowledge of the severity of the plaque 
formation.  Atherosclerotic plaque leads to secondary clinical events by any combination of the 
following three mechanisms: (i) thrornbolytic occlusion at the site of the stenotic plaque (ii) 
release of emboli that become lodged distally causing significant flow reduction, and (iii) chronic 
reduction of blood flow due to hemodynamic significant stenosis.  Stroke is the third leading 
cause of death in North America (Gorelick 1995).  Stroke is one conceivable secondary clinical 
event caused by atherosclerosis. 
A number of studies have estimated that up to 80% of al1 strokes could be prevented 
through lifestyle changes (Gorelick 1995).  An important step towards reducing stroke risk is to 
improve the identifying process of individuals who are at risk.  Accurate diagnosis and 
assessments of carotid atherosclerotic disease is paramount so that low-risk plaques and high-risk 
plaques can be differentiated.  Part of the vasculature that is of specific interest is the carotid 
bifurcation because it has been identified as a significant site for generation of cerebral emboli.  
While it is often difficult to determine the origin of an ischemic event retrospectively, it is 




vasculature.  It is now widely accepted that arterial geometry and hemodynamics influence the 
initiation and progression of disease (Glagov, Zarins et al. 1988). 
Regions of slow and recirculating blood flow are particularly susceptible to deposition of 
atheroma (Oshinski, Ku et al. 1995).  However, regions of high wall shear stress are associated 
with rupture of vulnerable plaque (Slager, Wentzel et al. 2005).  A robust correlation has been 
revealed between the degree of lumen narrowing (due to plaque) of the ICA and risk of stroke.  
Degree of lumen narrowing also correlates with optimal patient management, where 
symptomatic patients with severe stenosis are best treated surgically while those with mild 
stenosis are best managed by drug therapy.  These results have placed renewed emphasis on the 
development of clinical treatment techniques. 
Estimates of stenosis severity can be made directly from measurements of lumen 
geometry (Desouza, King et al. 1991; Smith, Rutt et al. 1996) or indirectly from measurements 
of blood-flow within diseased arteries.  Verifying the precision and accuracy of clinical 
techniques can be quite difficult since there is often no benchmark method in which comparisons 
can be made.  Because of these issues, objective evaluations of clinical techniques often include 
in vitro experiments using vascular phantoms with realistic geometries.  The next section 
presents a discussion on methods of treatment for atherosclerosis and arteriolosclerosis. 
 
2.2 Survey of Treatment Methods for Atherosclerosis and Arteriolosclerosis 
The first ground-breaking and still commonly used method of treating atherosclerosis is 
coronary artery bypass surgery.  In this treatment method, fragments of the great saphenous vein 
of the leg or small arteries from the thoracic cavity are used to construct a diversion (bypass) 




treatment technique in which a thin, flexible catheter is threaded into a coronary artery to the 
point of obstruction.  Afterward, a balloon tip is inflated to press the atheroma against the arterial 
wall which opens up the lumen.  The practicality of balloon angioplasty is limited to well-
localized atheroma. 
An additional method is laser angioplasty, which consists of an illuminated catheter 
which enables the surgeon to view the diseased interior of an artery on a monitor.  A laser is then 
used to vaporize atheromas and reopen the artery.  These treatment methods are cheaper and less 
risky than bypass surgery.  Conversely, there is particular concern that these methods of 
treatment may procure new injuries to the arterial walls.  As mentioned in Chapter 1, stents are 
also used as a tool for arteriosclerosis treatment.  Stents are implanted into the stenotic region of 
interest (ROI) on a balloon catheter, typically after angioplasty.  The stent is then expanded until 
plastic deformation occurs, providing scaffolding-like features.  The aim of the scaffolding 
feature is to prevent arterial recoil. 
Stents of two types are generally available: bare metal stents (BMS) and drug eluting 
stents (DES).  DES comprises of a pharmacologically active agent (medical treatment drug) that 
is delivered to the targeted stent deployment ROI site and is intended to reduce the stenosis.  In 
several cases, the medical drug is integrated into and released from a polymeric coating (Parker, 
Dave et al. 2010) of sufficient capacity to accommodate the selected dose and to modulate its 
delivery to the ROI (Yang and Burt 2006; Wessely 2010).  Provided that stents are extensively 
used for treatment of coronary artery disease, they often induce adverse biological responses.  
One response is reduction in lumen size as a result of formation of the neointima within the first 
year of stent implant surgery.  This process is termed restenosis.  Another response is formation 




Thrombosis and restenosis are the major drawbacks of coronary stent replacements 
(Topol and Serruys 1998; Kastrati, Mehilli et al. 2001).  Both restenosis and ST presents a major 
issue and limitation of BMS, yet has been the advent of DES.  Although all types of coronary 
stents can be associated with ST, there has been recent specific concern in relation to the ongoing 
risk of ST beyond six months after stent implanted surgery.  As opposed to BMS, DES prolongs 
the development of vessel repair including endothelialization, and can trigger a thromogenic 
response leading to late thrombosis.  Both these responses, restenosis and ST have been proposed 
to be affected by altered hemodynamics inside the stented vessels.  Percutaneous coronary 
intervention (PCI) of atherosclerotic disease located in coronary bifurcations has always been 
challenging, as a high restenosis rate persists even after implantation.  Numerous experiments 
have been performed on developing arterial stents (many of which involving animals), not to 
mention the need for clinical trials before accreditation is finally granted. 
The time period evolving from “a good stent design idea” to regulatory approval has led 
to the question of whether numerical modeling could be used to optimize stent designs. 
Undoubtedly, only those stents which show promising results in laboratory and clinical trials are 
retained and those that do not are discarded after considerable investment.  In the early years the 
drug release mechanism was very poorly understood, but through mathematical modeling 
approaches, combined with experiments, researchers have helped identify the dominant 
mechanisms of release in a number of stents.  While release experiments alone can give 
information regarding the release profile and the duration of release, the data generated is for one 
particular set of parameters (e.g. coating thickness, drug type and concentration) and the 




models have the advantage of allowing several parameters to be varied and the release profiles 
compared without the need to repeat the experiments.  
The ability of a numerical model to help identify the important parameters that govern the 
drug release is instrumental.  Numerical modeling can also play an important role when an 
understanding of the drug distribution within arterial tissue is required.  Cardiologists have often 
stressed that uniform drug concentrations across the wall are desired, and that these 
concentrations should be maintained within some minimum therapeutic and toxic levels. 
Obtaining this kind of information from experiments is extremely challenging, yet free and 
bound drug concentration profiles can readily be output from a mathematical model.  However, 
experiments and numerical modeling must go hand in hand.  The accuracy of the model results 
can only ever be as good as the quality of the inputs, especially when the model is sensitive to 
changes in one or more of the parameters. 
The accurate determination of system parameters remains one of the biggest challenges in 
the field due to the natural variation between species and the complexity involved in making the 
required measurements, especially in the in vivo situation.  However, some recent progress has 
been made by combining in vitro/ex vivo experiments with simple numerical models, and this 
approach may continue to yield useful results in the future.  Conclusions which can be drawn 
from modeling have provided useful insights, some of which are counter-intuitive.  Among the 
many other benefits of adopting a modeling approach include the potential to indicate at an early 
stage the designs that are doomed to failure, to design stents that are optimized and to result in a 
reduction in the number of experiments required.  The next section provides a comprehensive 





2.3 Numerical Modeling of Drug Release from Arterial Stents 
A vital aspect in the performance of any DES is the drug concentration/release profile.  If 
too much drug is delivered then toxicity can arise, whereas if too little drug is delivered then it 
may have no effect at all.  Of course, this „„therapeutic window‟‟ varies between drugs and 
between patients and after implantation.  Stent manufacturers routinely test the release of drug 
from their stents in an in vitro environment to gain an understanding of the shape of the release 
profile and to compare the release profile of different devices.  This allows the manufacturers to 
determine the repeatability of the release profile.  Whereas the in vitro release is unlikely to 
replicate the in vivo situation, it is nonetheless an important step in the development process.  
From the modeling perspective it makes sense to start with simple models, and in particular, it 
seems sensible to firstly consider modeling release in a controlled in vitro environment before 
embarking on the highly complex in vivo situation. 
A number of authors have focused specifically on modeling the release of drugs from 
DESs, electing to put to one side the range of complexities that are observed in the in vivo 
situation (including flowing blood, pulsatile nature of flow, wound healing, proliferation, 
migration of cells and complex uptake/binding).  This approach has proven to be useful in 
helping to address the question of which mechanisms are behind the release of drug from a 
number of stent systems and also in allowing estimates of parameter values (e.g. diffusion 
coefficients) to be made.  However, modeling drug release is not an area of research exclusive to 
DESs.  In fact, scientists have been devising models which describe the release of drug from 
tablet formulations and drug delivery devices for decades.  It is therefore not a surprise that the 





Newer generation DESs which have focused on biodegradable polymers and polymer-
free modified surface designs are likely to have more complicated mechanisms of release, and so 
it is of industrial relevance to consider these types of stents in their own right.  In the case of 
stents with biodegradable polymeric coatings, the drug release may involve diffusion, erosion 
and possibly dissolution and/or swelling (Siepmann and Siepmann 2008) and (Fredenberg, 
Wahlgren et al. 2011).  However, in the case of polymer-free stents, it is less clear how the 
sustained release is obtained and how this may be modeled.  Because of the complexities 
involved in systems which degrade as they release drug, a model which is shown to be accurate 
for one system may be useless for another.  Table 2.1 provides an overview of DES literature. 
Newer generation DESs which have focused on biodegradable polymers and polymer-
free modified surface designs are likely to have more complicated mechanisms of release, and so 
it is of industrial relevance to consider these types of stents in their own right.  In the case of 
stents with biodegradable polymeric coatings, the release of the drug may involve diffusion, 
erosion and possibly dissolution and/or swelling.  Some of the common processes which appear 
in these models include: hydration, degradation and erosion.  Hydration is simply the process of 
combining with water.  Degradation is a chain scission process which involves the breaking of 
polymeric chains by free radicals.  On the other hand, erosion is material loss from a system and 
can be either surface erosion or bulk erosion.  With surface erosion, water intrusion into the 
polymer is slow compared with the rate of degradation, thus the polymer is „eaten away‟ from 
the outside to the inside.  With bulk erosion, the rate of degradation is slow compared with the 
rate of water uptake and so the entire system is rapidly hydrated and degradation occurs 






Survey of Drug Eluting Stent Computational Studies. 
Author Study Parameters Conclusion Recommendations 
 
 
(X. Zhu 2014) 
This work presents 
a model that 
describes the 
integrated process 
of drug release in 
PLGA coating and 
subsequent drug 
delivery in the 
arterial wall. 
Bound, internalized, 
and free drug 
concentration and strut 
embedment 
The developed model 
here provides the basis  
for evaluating and 
studying a PLGA 
coating for stent 
applications, 
with the ease of 
adaptation to more 
sophisticated scenarios 
(e.g., consideration of 
more pathological 
conditions).  
Factors related to the 
pathological conditions; 
such as plaque, thrombus, 
and regions of tissue 
compression should be 









of (1) the delivery 
of a hydrophobic 
drug from a drug-
eluting stent with 
biodurable  
polymeric coating 
and (2) drug 
distribution in 
the arterial wall 
with reversible 
binding. 
Free and bound drug Drug release from 
an implanted drug-
eluting stent is 
affected by the 
surrounding arterial 
wall via the vascular 
drug diffusivity 




difference from in 
vitro release 
behaviours of a 
hydrophobic drug.  
Future studies should 
incorporate design 





(M. Horner. 2010) 
The main goal of 
this study was to 
combine a realistic 
geometry for the 
deployed stent and 




model for drug 
transport.  
 
Free and bound drug The model was shown 
to exhibit the correct 
behavior when drug 
binding affinity, 
diffusivity, and wall 
plasma convection 
were varied. 
Therefore, the model 
is useful for studying 
the effect of drug 
physicochemical 
properties and local 
transport factors on 
drug distribution and 
retention in the vessel 
wall. 
Future directions for this 
work include modeling 
the coating and finite 
drug reservoir, the 
presence of thrombus, or 
allowing for neighboring 
or overlapping stents. The 
latter might require the 
inclusion of luminal 
flow in the model to 
achieve the correct 
delivery patterns 
 
Prabhu and Hossainy (2007) focused specifically on the degradation and release of 




using in vitro data.  The model considers two non-linear reactions: the hydrolysis (by water 
intrusion) of PLA to produce oligomers and lactic acid and the hydrolysis of oligomers to 
produce lactic acid. Five reaction diffusion equations are presented to describe the temporal and 
spatial evolution of the concentrations of water, PLA, oligomers, lactic acid and everolimus.  The 
model equations were solved using an iterative finite difference approach which updates 
estimates of the various parameters via comparison with the experimental data.  The authors 
indicate that autocatalysis (i.e. a reaction where the reaction product itself is the catalyst of the 
reaction) is important and cannot be ignored. While not directly focusing on DESs, (Siepmann 
and Gopferich 2001) provided a review of the mathematical modeling of bioerodible polymeric 
drug delivery devices.  The authors considered only systems where the drugs are physically 
immobilized within a water insoluble polymeric matrix.  The authors stressed that accurate 
physiochemical characterization of the investigated system is an absolute pre-requisite for the 
appropriate mathematical modeling of the device, and as such they detail techniques to 
experimentally characterize degradation and erosion.  These can help identify whether the 
erosion is surface or bulk and assist in clarifying the time-dependence of the diffusion 
coefficients. 
The model used in the study of (Lee 1980) lends itself to an approximate analytical 
solution for drug release from thin eroding films and the models of (Joshi and Himmelstein 
1991) which accounts for acid producing species that accelerate matrix hydrolysis. The authors 
comment that modeling efforts should try to take into account the in vivo   conditions since, for 
example, cellular tissue reactions can affect the degradation process. Again, not referring 
specifically to DESs, (Rothstein, Federspiel et al. 2009) present a unified model for the 




accounts for the transition from surface eroding to bulk eroding behaviour during the course of 
degradation.  The study of (Soares and Zunino 2010) introduced a mixture model for water 
uptake, degradation, erosion and drug release from polydisperse polymeric networks.  Each 
constituent of the model represents chains of an average size.  A multiscale description of 
degradation and erosion is proposed, combining the molecular description of scission with Fick‟s 
macroscopic laws of diffusion.  The approach adopted here describes degradation by means of 
the time evolution of weight fractions of polymeric constituents of average degree of 
polymerization.  The authors argue that the key advantage of their model is the fact that polymer 
degradation is described as an individual chemical reaction.  
In the study of (Baran, Ogino et al. 1997), a bioresorbable DES model based on detailed 
constitutive equations and taking into account the main physical and chemical mechanisms 
involved in coating degradation, drug release and restenosis inhibition was used.  Their results 
were verified against selected in vitro   and in vivo   data available in the literature.  In the study 
of (Hill 1983), the authors considered a two dimensional dissolution–diffusion model which also 
included surface erosion.  In the study of (Korakianitis and Shi 2006), the authors reported that 
the drug may exist in the coating in a form which needs to dissolve before it can diffuse.  The 
authors considered the drug in polymer as two separate phases: a dissolved phase and a solid 
phase with concentrations CfCf and CbCb, respectively.  Only dissolved drug is allowed to 
diffuse.  The authors included a source term in the diffusion equation to account for the solid 
phase dissolution.  The next section presents a review of literature on modeling the drug 




2.4 Survey of Numerical Drug Eluting Stent Studies 
Modeling the release of drug from arterial stents is only a one part of the story.  What 
happens to the drug after it is released in vivo is of more clinical interest and certainly more 
difficult to model.  Clinicians advise that a uniform drug concentration should be attained across 
the arterial wall, and the concentration should be maintained within some therapeutic window. 
Thus an understanding of the structure and components of the arterial wall is crucial.  The 
arterial wall is a porous heterogeneous structure, consisting of three distinct layers. Closest to the 
lumen is the intima, followed by the media and finally the adventitia (Panerai 1980). 
The intima consists of the sub-endothelial space and the endothelial layer of cells, known 
as the endothelium.  This layer is crucial to the control of the normal function of the artery, 
through its mediation of relaxation and contraction and via its control of smooth muscle cell 
proliferation within the underlying media layer.  The internal elastic lamina forms the outermost 
part of the intima.  The media region comprises smooth muscle cells, collagen and elastin.  
Finally, the outermost layer of the arterial wall is the adventitia.  The adventitia tethers the artery 
to perivascular tissue, and contains cells known as fibroblasts as well as a network of small blood 
vessels, called vasa vasorum, which act as a blood supply to the adventitia and provide a 
clearance mechanism for drugs released into the artery wall. 
2.5 Survey of Current Bifurcation Stent Implant Issues 
The introduction of polymer-based anti-flammatory and anti-proliferative drugs released 
in a controlled manner from coronary stents has changed the treatment results of PCI 
considerably.  However, patients with certain multifaceted lesions have consistently been 
excluded from most trials undoubtedly because of the combined distress of problems with 




and clinical results.  Coronary bifurcations are periodically encountered and roughly 15-20% of 
percutaneous coronary interventions (PCI) are implemented to treat bifurcations (Latib, Colombo 
et al. 2009).  PCI for bifurcation disease has been deliberated as a technically challenging 
procedure.  PCI has also been associated with lower procedural success rates and inferior clinical 
outcomes than bifurcation lesions.  Furthermore, there has also been enormous uncertainty and 
debate as to the most appropriate treatment strategy when dealing with bifurcations.  However, in 
recent years noteworthy improvements have occurred in the overall understanding and treatment 
of bifurcation lesions. 
Initially, the introduction of DES have meaningfully reduced restenosis and repeat 
revascularization rates demonstrated in both archive studies and a sub-analysis of the randomized 
SCANDSTENT trail (Steigen, Maeng et al. 2006; Thuesen, Kelbaek et al. 2006).  
SCANDSTENT was a randomized, controlled study that showed the beneficial effect of drug-
eluting stents compared with bare-metal stents in a large series of entirely complex coronary 
artery lesions.  The superiority of the sirolimus-eluting stent was evident in all subgroups of 
patients, and among patients who had received the drug-eluting stent, target lesion 
revascularization was only necessary in those with bifurcation lesions. 
Early results using balloon angioplasty alone to treat bifurcation lesions demonstrated 
relatively low angiographic and clinical success rates and high restenosis (George 1986).  
Although the introduction of coronary stents resulted in more predictable results and higher 
success rates, angiographic restenosis rates remain high, despite the use of different approaches 
(Lefevre, Louvard et al. 2000; Sheiban, Albiero et al. 2000; Yamashita, Nishida et al. 2000; 
Karvouni, Di Mario et al. 2001).  Additionally, a more selective usage of two stents as intention 




(SB) due to the fact that many residual stenosis at the SB may not be physiologically significant.  
Fourthly, the better performance of two stent techniques associated with high pressure post 
dilatation, kissing inflation and possible intravascular ultrasound; and finally the publication of 
numerous trails specifically in bifurcations. 
Consequently, these changes and outcomes after bifurcation PCI have improved 
considerably and in some studies approximate those of non-bifurcation PCI.  There have recently 
been randomized trails and a large archive comparing provisional strategy of main branch (MB) 
stenting with 1 DES vs. a 2 DES strategy of stenting both branches.  From these reports, it is 
evident that the percutaneous treatment of coronary bifurcation has progressed in a manner that 
one stent vs. two stent appears to have been resolved.  The provisional approach of implanting 
one stent on the MB is now considered the default approach in most bifurcation lesions.  This 
approach is mainly due to the fact that routine implantation of two stents does not give superior 
results compared to selective usage. 
Despite the simplicity of the provisional approach, this technique frequently leaves the 
SB with a significant residual stenosis (most trials evaluating the provisional approach quote 
success as 30% residual on the MB and less than 50% residual on SB).  The results follow 
implantation of two stents is sometimes suboptimal and therefore the follow up is inferior to 
expected.  Operator experience, willingness to devote sufficient time and effort to optimize the 
result (especially on the SB) and usage of intravascular ultrasound elements frequently needed 
when implanting two stents.  In the work of (Latib, Colombo et al. 2009), the authors 
experienced a stricter adherence to this approach and the results have contributed to the 
improvement seen over the last few years following implantation of two stents in bifurcation 




this task and change the current proposed approach to bifurcation treatment.  Presently routing 
stenting of both branches appears to offer no advantage over a provisional approach.  A more 
detailed overview can be found in (Colombo, Moses et al. 2004).  The next section presents a 
discussion on fluid-structure interaction of arteries. 
2.6 Survey of Computation Arterial Hemodynamic Studies 
In the efforts to analyze the cardiovascular system and effects of diseases on it different 
ways of analyzing hemodynamic parameters are practical such as lumped model, one, two or 
three dimensional modeling and experimental methods.  In this section lumped, one, two and 
three dimensional models are discussed.  Lumped models (zero dimensional) and one 
dimensional models are electrical circuitry models that provide only time dependent data for 
hemodynamic studies.  Electrical components used in the electrical circuit are used as a surrogate 
for fluid parameters.  A review of lumped and one dimensional studies are provided in Table 2.2. 
The use of mathematical models in the simulation of cardiac dynamics plays a vital role 
in understanding cardiac physiology and pathology and possible treatment techniques.  Early 
studies were performed to understand and simulate healthy cardiac dynamics at the physiological 
scale (Arai, Alpert et al. 1993) or to describe cardiac contraction (Aroney, Herrmann et al. 1989).  
For example, researchers have developed several time varying elastic models for modeling the 
ventricular at the organ level.  Mathematical functions took over the role to initiate the 
simulation of the hemodynamics at the organ level (Arts, Bovendeerd et al. 1991; Beuckelmann, 
Nabauer et al. 1992; Beltrami, Finato et al. 1994; Atar, Gao et al. 1995).  In these models, the 
activation function was defined using trigonometric, polynomial or exponential functions.  In 





Survey on One Dimensional Cardiovascular modeling techniques. 
Application Model Feature  Studies 
Ventricular assist device support 
for heart failure 
The native cardiovascular system was in 
heart failure condition, and a VAD model is 
coupled 
1. Studies of cardiovascular response in the heart 
condition of VADs (Voitl 2009) 
2. Studies of cardiovascular response in the heart 
failure condition support with intra aortic 
balloon pumps 
3. Comparison of the assistance action of different 
types of VAD and VAD motion profiles. 
4. Study of the effect of the inlet and outlet 
cannulation sites for connecting the VADs to the 
native cardiovascular system. (Shi, Korakianitis 
et al. 2007) 
5. Study of the physiological control of pulsatility 
gradient in rotary blood pump (Bhattacharya-
Ghosh, Bozkurt et al. 2014) 
 
Study of cardiovascular response 
under neuro-regulation 
 
The native cardiovascular system was 
coupled with the models for the 
nervous system 
 
1. Simulate the cardiovascular responses under 
neuro-regulation in various conditions of 
isocapnic hypoxia hypercapnia and hypocapnic 
hypoxia  (Ursino and Magosso 2000; Shi, 
Lawford et al. 2011) carotid occlusion (Aquino, 
Robinson et al. 2014) 
2. Simulation of cardiopulmonary response in 
Valsalva manoeuvre (Lu, Clark et al. 2001; 
Aboamer, Azar et al. 2014) 
3. Simulation of the cardiovascular response to 
orthostatic stress (Shaw, Loughin et al. 2014) 
 
As boundary condition in 




The 0-D circulation system model was 
coupled with the distributed parameter 
models (1D, 2D or 3D). 
 
1. Multi-scale simulation of the cardiovascular 




However, in a failing heart a number of changes occur due to pathophysiologic mechanisms at 




Some models have attempted to understand the underlying mechanisms of contraction by 
increasing the level of complexity of mathematical models used to describe them, via the 
addition of relevant processes at different biological scales.  For example in the study of 
(Hossainy and Prabhu 2008), the authors described the relationship between left ventricular 
pressure and volume, as well as systolic fiber stress and strain in the wall (Hossainy and Prabhu 
2008) driven by an activation function to simulate the hemodynamics over a cardiac cycle. This 
model simulates the contraction of a single fiber at microstructural level, and extends this to a 
complete ellipsoid ventricle at microscopic level assuming homogeneous distribution and 
function of all muscle fibers, thus rendering ventricular hemodynamics.  (Cox, Loerakker et al. 
2009) used this model to describe the right ventricular hemodynamics in a healthy and 
pathological configuration by modifying the wall volume and zero pressure volume in the left 
ventricle (Cox, Loerakker et al. 2009).  Diaz-Zuccarini and LeFevre (2007) modelled the 
contraction of a sarcomere and defined the ventricle as a cylinder.  Also here, the ventricular 
dynamics were obtained with the assumption of a uniform sarcomere distribution in the ventricle. 
Other models focus on cardiac cells and include the generation of the action potential. 
For example, the Luo–Rudy model (Luo and Rudy 1994) is widely used in electrophysiological 
literature to describe the ion fluxes and channel currents of a ventricular myocyte resulting in the 
transmembrane (action) potential.  The numerical reconstruction of the ventricular action 
potential is based on a Hodgkin–Huxley type approach (Luo and Rudy 1994). An advanced 
model of the Luo–Rudy model is given by Livshitz and Rudy (Livshitz and Rudy 2009) 
accounting for the ion channel kinetics, calcium handling, and dynamic changes in the 
intracellular/extracellular milieu during the action potential. To consider the relevance of 




myocyte, the sliding filament model (SFM) (Rhodes, Ropella et al. 2003) describes its 
interaction and sensitivity with myofilaments within a sarcomere at the protein level. 
The cardiac cell models mentioned above have been used to simulate physiological and 
clinical situations.  However, these models do not take into account the connection between 
different biological scales, which is crucial for understanding cardiac physiology as a holistic 
process.  Various approaches have been undertaken to understand the coupling between 
microscopic and macroscopic elements of the cardiac contraction and its physical mechanisms 
using mathematical models.  Bhattacharya-Ghosh et al. presented a blueprint for a multi-scale 
model of the ventricle (Bhattacharya-Ghosh, Schievano et al. 2012).  This model describes 
events in which relevant mechanisms are mathematically described and coupled at the protein, 
cellular and organ scales in order to provide a better understanding of the combined ECCP as a 
whole.  However, this model does not incorporate the four heart compartments and circulatory 
loop. 
A three-parametric model of heart muscle behaviors was introduced (Zacek 1996) and a 
modification of this model was presented later (Rideout 1991).  It successfully predicted force 
development during a time period of heart, showing deactivation of the contractile element 
during isotonic shortening and the apparent dependence of series stiffness in time.  The study of 
the series elasticity of cardiac muscle was presented (Rupnic 2002).  Afterwards, the time-
varying elastic model of the left ventricle was introduced and later the relationship between 
pressure-volume area and cardiac oxygen consumption was described (Helde 2002).  Finite 
element methods are commonly used to simulate the left ventricular way of operation.  The first 
computer models describing the arterial system were presented in the sixties.  The authors 




computer, which allowed simulation of different physiological and pathological conditions.  This 
model was extended in detail later (Wang 2004).  Also, blood flow through site of particular 
interest of the arterial tree such as anastomoses, stenoses and bifurcations can be described with 
finite element method simulation.  The mathematical analysis of the whole human cardiovascular 
system remains as a complicated task and for that reason models are simplified with respect to 
particular parts of interest.  
There is no single mechanism that can account for atherogenesis, other than being 
interpreted as the complex interaction of many processes (Van Wyk, Wittberg et al. 2014).  
Different slow acting biochemical and mechanical processes have been linked to the initiation or 
progression of the disease.  The most recent sets of hypotheses relate low time-averaged and 
oscillatory wall shear stress (WSS) to regions prone to disease (Bharadvaj, Mabon et al. 1982; 
Bharadvaj, Mabon et al. 1982; Zarins, Giddens et al. 1983; Ku, Giddens et al. 1985; Gambillara, 
Montorzi et al. 2005).  These fluid mechanical aspects are thought to increase residence times 
favorable to near wall biochemical processes and transport mechanisms of atherogenic materials 
towards these near wall sites (Bharadvaj, Mabon et al. 1982; Bao, Lu et al. 1999). Other studies 
suggest that high WSSGs lead to cell dis-orientation in the endothelial layer (DePaola, Davies et 
al. 1999; Nagel, Resnick et al. 1999; Farmakis, Soulis et al. 2004) or intimal hyperplasia that are 
regarded as possible initiators to atherogenesis (Depaola, Gimbrone et al. 1992; Haidekker, 
White et al. 2001; White, Haidekker et al. 2001).  The analysis of each of these hypotheses is 
compounded by the pulsatile nature of blood flow and the consequentially large spatial flow 






Review of Arterial Hemodynamic Computational Studies. 
Authors Study Parameters Conclusion Recommendations 
(Xiang, Siddiqui et al. 
2014) 
The objective of this 
study was to examine 
the sensitivity of 
widely used 
hemodynamic factors 
derived from CFD to 
different inlet 
waveforms under the 
same inflow rate.  
This study specifically 
focus on WSS and 
OSI, the two 
independent 
parameters predictive 
of rupture in our 
multivariate logistic 
regression model  
The authors stress that 
patient-specific flow 
boundary conditions 
are highly desired for 
image-based CFD 
simulations.  However, 
only a few CFD 
studies have them  
For studies of large 
cohorts aiming at 
finding statistical 
correlations between 
aneurysm rupture and 
hemodynamics, we 
may have to use non-
patient-specific inlet 
boundary conditions in 
the current situation. 
(Xiang, Tutino et al. 
2014) 
In Part 1 of this 2-part 
review, a hypothesis is 
proposed which 
includes:  both high 
and low wall shear 
stress drive intracranial 
aneurysm growth and 
rupture through mural 




respectively.  Part 2, 
delineates different 
wall shear stress 
parameter definitions 
and survey recent 
computational fluid 
dynamics studies. 
Wall shear stress Computational fluid 
dynamics findings 
correlating both high 
and low wall shear 
stress with intracranial 
aneurysm growth and 
rupture puzzle 
researchers and 
clinicians alike. These 
conflicting findings 
may stem from 
inconsistent parameter 
definitions, small 
datasets, and intrinsic 
complexities in 
intracranial aneurysm 
growth and rupture. 
Refinements are 
needed which will 
yield more accurate 
predictive models for 
intracranial aneurysm 
risk assessment from 
computational fluid 
dynamics 
(Qiu, Fei et al. 2013) This paper studies the 
influence of a High-
Porosity Mesh (HPM) 
stent on the 
hemodynamic 
characteristics in the 
intracranial aneurysm 
based on the 
Computational Fluid 
Dynamics (CFD). An 
idealized basilar tip 
aneurysm model and a 
HPM stent model was 
built. 
Wall shear stress The following 
conclusions can be 
drawn: when applying 
the stent to treat the 
aneurysm, the wires of 
the stent impede the 
blood flow into the 
aneurysm sac, which 
would significantly 
reduce the magnitude 
of the impact force of 
the blood flow, the 
pressure and the WSS 
at the dome of the 
aneurysm wall. 
Future results should 
not only provide a 
valuable reference for 
optimizing the stent 
design, but also help 
neurosurgeons to select 
suitable stents and to 
establish reasonable 
operation procedures. 
(Hewlin and Kizito 
2011) 
 Wall Shear stress, 
Normal Stress, and 
vorticity 
dynamic behaviors of 
blood through the 
patient-specific carotid 
bifurcation arterial 
geometries based on 
numerical approaches 
showed differences 
when compared to a 
simplified model 




from experimental data 
from flow phantoms or 
as an alternate blood  




In order to study these hypotheses several experimental and numerical investigations 
implement various mean WSS based indicators to simplify the analysis of the temporal WSS 
variations in identifying atherosclerotic prone locations (Zarins, Giddens et al. 1983; Ku, 
Giddens et al. 1985; Pedersen, Oyre et al. 1999; Lei, Giddens et al. 2001; Soulis, Giannoglou et 
al. 2007).  These indicators include the time averaged WSS (TAWSS), oscillatory shear index 
(OSI) and relative residence time (RRT).  In the quoted studies indicators are usually shown to 
be well correlated with plaque affected regions, however also possibly in agreement with un-
affected regions.  The application and usefulness of these indicators in more complex arterial 
junctions is therefore not well understood.   
 
2.7 Survey of Flow Phantoms and Measurement Techniques 
Flow phantoms are a vital tool for studying hemodynamics of arteries using Doppler 
Ultrasound (DS) and Particle Image Velocimetry (PIV).  In the production of realistic flow 
conditions, it is highly desirable to be able to produce arbitrary geometries, including branching 
stenosis, that closely mimic in vivo geometries.  Usually, wall-less vessels have been employed 
to avoid mismatch problems in acoustic properties (Patterson and Foster 1983; Rickey, Picot et 
al. 1995; Guo and Fenster 1996), and to produce more complicated geometries by using a lost 
material casting technique (Poepping et al. 2002; Smith et al. 1999).  Conversely, with 
employing wall-less vessels, the tissue-mimicking material (TMM) may be susceptible to 
changes due to exposure to air or water (Hoskins and Tamanarine 2000), incompatibilities with 
the blood-mimicking fluid (BMF) or breakage and leakage problems, as addressed by 
(Ramnarine, Anderson et al. 2001).  Therefore, it is also desirable to have a completely sealed 




A number of flow phantoms are reported in the literature and have been reviewed by 
(Hoskins 1997).  However, most of the flow phantoms previously developed have consisted of a 
simple geometry, such as straight tubes, or a stenosed geometry formed by shrinking tubes, 
inserting tapers or extracting rods.  The development or more realistic phantom geometries has 
been primarily limited by the lack of versatile vessel-mimicking materials (VMMs).  A major 
consideration for the development of a new VMM was the ability to fabricate a robust flow 
phantom, with vessels of anatomically accurate models, which can withstand physiological flow 
stresses.  Key design considerations include robustness, stability, elasticity, wall thickness, speed 
of sound, acoustic attenuation, echogenicity and, finally, practical considerations for fabrication, 
such as versatility, variations in echogenicity and the incorporation of plaques or irregular 
surfaces. 
Additionally, the main physiological features to be included are the wall thickness and 
elasticity.  It is necessary to match the wall thickness for realistic imaging and to match the 
elasticity because of its contribution to the damping and propagation of the pulsatile waveform 
during flow. Studies have shown that the wall thickness of the carotid arteries is approximately 
0.65 to 0.95 mm, depending on gender, race and duration of diabetes (Riley, Barnes et al. 1992; 
Folsom, Eckfeldt et al. 1994; BonithonKopp, Touboul et al. 1996; Wagenknecht, Dagostino et al. 
1997).  Also, arterial walls have been shown to have a nonlinear elastic behavior (Roach and 
Burton 1957), due to the different elasticities of the elastin and collagen components.  The 
Young‟s elastic modulus of elastcity, 0.3 MPa is much lower than that for collagen, 300 to 2500 
MPa (Dobrin 1978), and the resulting arterial elasticity is similar to elastin for normal 
physiological strains, and approaches that of collagen for much higher strains.  The incremental 




abdominal aorta sections, to range from approximately 0.04 to 2 MPa for corresponding 
transmural pressures of 0 to 90 mmHg (0 to 12 kPa) (Drangova, Holdsworth et al. 1993) and, in 
the human iliac artery, to range from approximately 0.05 to 1.45 MPa for transmural pressures of 
0 to 120 mmHg (0 to 16 kPa) (Ryan and Foster 1997). 
The critical acoustic properties to be matched are the speed of sound (SoS) and the 
acoustic attenuation.  Preferably, a VMM should be acoustically well matched to both the BMF 
and the TMM.  A disparity in the speed of sound between the VMM and surrounding material 
(BMF or TMM) will produce reflection and refraction of the US beam, which can result in 
distortion of the Doppler spectrum (Thompson, Aldis et al. 1990). Few suitable materials have 
been found that match both the acoustic attenuation and the SoS of soft tissue (0.5 to 0.7 dB/cm 
MHz and 1540 m/s, respectively).  Many materials have been investigated and described for use 
as the VMM in flow phantoms, as seen in the review by (Law, Johnston et al. 1989).  C-flex  
(Cole-Parmer, Vernon Hills, NY) is one popular choice for a VMM, with a speed of sound (1553 
m/s) similar to that of tissue, but with a much higher attenuation (28 dB/cm at 5 MHz) that varies 
with frequency to the power of 1.8 (Ramnarine, Anderson et al. 2001).  Unfortunately, most of 
the materials suggested as a VMM are generally available only as ready-made tubing, such as C-
flex and latex, and are, thus, limited to straight-tube or stenosed-tube geometries with a 
manufacturer- specified wall thickness and fixed echogenicity. 
Silicone allows the opportunity to produce vessels with arbitrary wall thickness and 
lumen geometry, due to its availability in a liquid form that can be cast to form a flexible 
transparent elastomer.  These elastomers are strong, yet compliant, chemically stable over time, 
and do not absorb a significant amount of water (unlike latex rubber).  Silicone has been used 




Stergiopulos et al. 1994), stenosed tubes for laser visualization and branched vessel models for 
flow visualization (Melbin, Gopalakrishnan et al. 1982), by painting layers of an elastomer 
(Sylgard 184) onto a rod or cast.  A casting technique has also been used with this material to 
produce a branched carotid model for use with laser Doppler velocimetry and flow visualization 
(Cao and Rittgers 1998; Secomski, Nowicki et al. 2003).  In what follows, the fabrication of a 
sealed, US compatible, flow test object that consists of a thin-walled silicone-elastomer vessel of 
arbitrary geometry embedded in a TMM is discussed. 
Doppler methods are extensively used to quantify and visualize blood velocity in clinical 
practice.  Typically the maximum velocity waveform is used to quantify the degree of lumen 
reduction in stenosed arteries, and indices based on the maximum velocity are used to quantify 
the shape of the waveform.  Further quantification has been used in research, studies such as the 
measurement of velocity profile and volumetric flow (Picot and Embree 1994; Bohs, Friemel et 
al. 1995; Picot, Fruitman et al. 1995), wall shear rate (Brands, Hoeks et al. 1995; Forsberg, 
Morvay et al. 2000) and turbulence intensity (Poepping, Nikolov et al. 2002; Thorne, Poepping 
et al. 2008).  The process of measurement of velocity and related quantities using ultrasound is 
complex and prone to error (Blake, Easson et al. 2009).  Maximum velocity errors using spectral 
Doppler in clinical ultrasound systems have been reported in the range of 0-100% (Hoskins 
1997).  The maximum Doppler shift arises from one edge of the Doppler aperture, whereas angle 
correction is performed with respect to the center of the aperture (Hoskins and McDicken 1991) 
Several CFD studies have examined flow through stenosed arteries.  However, these 
studies normally depend on turbulence models that agree poorly with published experimental 
values.  (Blake, Easson et al. 2009) reported that direct numeric simulation (DNS) of turbulence 




restricts their applications.  While conventional CFD (i.e., non-DNS CFD) have been used to 
investigate flow in complex geometries, the geometry becomes more complex and the agreement 
between the CFD and experimental data is poorer.  This discrepancy arises such that it is not 
understood whether it is the CFD or the experimental technique that is at fault or both.  This 
situation outlines the need for validation methods based on experimentally measured data. 
Previous experimental studies have used stenosis models to investigate the variation of 
measured velocity with degree of stenosis (Hoskins 1997; Poepping, Nikolov et al. 2002; Steel, 
Ramnarine et al. 2003).  Generally, these studies contemplate the variation of estimated peak 
velocity with machine settings and with the degree of stenosis.  (Bascom, Johnston et al. 1997) 
compared measured velocity using DUS with flow field visualization data measured using a 
photochromic technique.  Both the ultrasound technique and the photochromic technique used 
either the same acrylic stenosis model or geometrically identical models.  However, it is known 
that acrylic has a high speed of sound more than 2500 m/s (Hoskins 2008), which leads to 
distortion of the Doppler beam.  In general, materials such as glass and Perspex, which are 
suitable for optically-based flow studies have very high values of the speed of sound and are 
unsuitable for use in ultrasound phantoms, which require materials whose speed of sound is 
closer to 1540 m/s. 
(Blake, Meagher et al. 2008) developed a technique to estimate the wall shear rate in 
healthy arteries using a clinical ultrasound scanner.  The method used a theory of fully developed 
oscillatory flow together with a spectral Doppler trace and an estimate of mean arterial diameter.  
A method using color of flow imaging was compared with the spectral Doppler method in 
vascular phantoms and was found to have errors that were on average 35% greater.  Differences 




varied by artery: brachial 9%, carotid 7%, femoral 22%, and fetal aorta 17%.  Test measurements 
obtained from one healthy volunteer demonstrated the feasibility of the techniques in vivo. 
Blake, Meagher et al. 2008) used walled vascular phantoms with different lumen 
diameters to mimic the physiologic conditions for a range of arteries.  The vascular phantoms 
were constructed from acoustically equivalent tissue-mimicking material (TMM) (Teirlinck, 
Bezemer et al. 1998) with a vessel-mimicking material made from c-flex tubing (Cole-Parmer, 
London, UK).  Perspex boxes of dimension 30 x 10 x 10 cm (L x W x D) (Mike Bisset Plastics, 
Livingston, UK) were used to build the phantoms.  Stainless steel rods of the appropriate 
diameter (RS Components, Corby, UK) were pushed through the tubing, which was 
subsequently pushed through the sides of the boxes and sealed with silicon.  The liquid agar 
TMM was poured into the boxes.  When the agar had set, the stainless steel rods were 
withdrawn, creating the arterial lumen inside the vessel mimic. 
 






Each vascular phantom was connected into a flow driven by a gear pump (Micropump model 
132, Micheal Smith Engineers Ltd., Surrey, UK) powered by an electric motor (M586TE, 
McLeannan Servo Supplies Ltd., Surrey, UK) and an external amplifier (4020-LS, Aerotech 
Ltd., Berkshier, UK).  For the brachial and fetal aorta phantoms the working fluid was 
acoustically equivalent to human blood. 
 
Figure 2.2. Schematic diagram of the flow circuit used in the study (Blake, Meagher et al. 2008). 
 
There is a need to develop a method for validation of velocities measured in the region of 
a stenosis.  This paper describes the development of a paired-phantom system for validation of 
velocity in the region of a stenosis, based on the use of particle image velocimetry.  (Blake, 
Easson et al. 2009) developed a dual-phantom system for validation of velocity measurement in 
stenosis models.  Pairs of phantoms with identical geometry and flow conditions were 
manufactured, one for ultrasound and one for particle image velocimetry (PIV).  The PIV model 




1.41 of silicone.  Dynamic scaling was performed to correct for the increased viscosity of the 
PIV fluid compared with that of the ultrasound mimic.  The degree of stenosis in the model pairs 
agrees to less than 1%.  The velocities in the laminar flow region up to the peak velocity location 
agreed to within 15%, and the difference could be explained by errors in ultrasound velocity 
estimation.  At low flow rates and in mild stenosis, good agreement was observed in the distal 
flow fields, excepting the maximum velocities.  At high flow rates, there was considerable 
difference in velocities in the postenosis flow field (maximum centerline differences of 30%), 
which would seem to represent real differences in hydrodynamic behavior between the two 
models.  Sources of error included: variation of viscosity because of temperature (random error, 
which could account for differences of up to 7%); ultrasound velocity estimation errors 
(systematic errors); and geometry effects in each model, particularly because of imperfect 
connectors and corners (systematic errors, potentially affecting the inlet length and flow 
stability) 
 




Briefly, the flow circuit consisted of the vessel phantom described before connected to a gear 
pump at one side and a reservoir at the other side.  The inlet was flush with the channel in the 
flow phantom and straight for a distance of one meter to ensure fully developed flow at the 
isonation site.  The gear pump was computer controlled and able to provide steady or pulsatile 
flow.  The blood mimic consisted of suspension of 5 micron nylon particles in a glycerol/dextran 
solution whose acoustic and viscous properties were blood equivalent.  The flow rate through the 
circuit was measured with a graduated cylinder and a stopwatch. 
 
Figure 2.4. Schematic of the stenosis geometry with 30% diameter reduction (length not to 
scale).  Obtained from the study of (Shuib, Hoskins et al. 2011). 
 
Laser Doppler velocimetry (LDV) has been used to provide quantitative flow 
information, providing spatial velocity profiles and wall shear stresses (Bharadvaj, Mabon et al. 
1982; Motomiya and Karino 1984; Ku and Giddens 1987; Rindt and vonSteenhoven 1996).  In 
the study of (Motomiya and Karino 1984), detailed quantitative information on flow streamlines 
within the carotid bifurcation by photographing a suspension of polystyrene particles in 
wintergreen oil using a cine camera were obtained.  Images were analyzed frame by frame to 
provide detailed maps of flow lines, including quantification of flow velocities, and of wall shear 




sinus where wall shear stresses are very low, whereas along the inner walls of the bifurcation the 
flow is parallel to the vessel walls and shear stresses are high.  The regions of low wall shear 
stress correlated well with the known tendency of atherosclerotic lesions to form in the carotid 
sinus, with the inner walls of the bifurcation typically remaining disease-free (Samuel 1956; 
Solberg and Eggen 1971).  This study represented a precursor to current particle image 
velocimetry (PIV) techniques, which use sophisticated computer algorithms to analyze the 
particle images. 
Color Doppler ultrasound imaging (DUS) provides an additional means to visualize and 
quantify the flow in models of the carotid bifurcation.  In vitro DUS studies of a carotid 
bifurcation model, (Polak, Oleary et al. 1990) showed regions of flow reversal in the carotid 
sinus. This corresponds to the region of flow reversal and recirculation observed by flow 
visualization techniques and LDV.  Although most previous in vitro studies have been performed 
in models of healthy arteries, the flow through a carotid bifurcation model with a 25% stenosis in 
the sinus has also been investigated (Palmen, Vandevosse et al. 1994; Gijsen, Palmen et al. 
1996). Hydrogen bubble visualization, LDV measurements, and corresponding computational 
flow dynamics CFD analyses showed that this minor stenosis had only a small effect on the flow 
fields. 
The experimental techniques currently available for quantitative analysis in arterial flow 
models each have their unique strengths and weaknesses. Previous quantitative studies in the 
carotid bifurcation have mainly used LDV, which provides high spatial and temporal resolution 
;10 mm, ;100 kHz!. However, LDV is very tedious when used to map a velocity field, since the 
velocity can only be measured at a single point at one time. PIV techniques are far more 




instantaneously. However, PIV has lower spatial and temporal resolutions ~.0.25 mm, and 
typically 15 Hz; up to 1000 Hz available at prohibitive cost.  Both LDV and PIV can only be 
used in transparent models. DUS and magnetic resonance velocimetry (MRV) both have rather 
low spatial resolution compared to LDV and PIV ~cf. 3 mm for DUS and 1 mm for MRV. 
However, DUS and MRV both have the advantage that they can be used in vivo, enabling direct 
comparison between in vitro and in vivo studies.  Modeling or measuring wall and fluid shear 
stresses is challenging even in healthy blood vessels. Even more daunting is the characterization 
of shear stresses in the highly irregular lumen of a diseased blood vessel. Currently, no available 
technique can measure the real time distribution of velocities in vivo, and therefore shear stresses 
have been, at best, estimated. 
2.8 Literature Review Conclusions 
A review of literature on numerical and experimental modeling of the cardiovascular 
system under diseased and non-diseased cases has been presented.  For DES modeling, the drug 
release in the arterial walls via DES, computational arterial hemodynamic studies, and arterial 
phantoms has been presented.  Presently, the majority of DES studies have incorporated 
reversible binding reactions.  The most noteworthy recommendations for DES studies are: (1) 
incorporating factors related to the pathological conditions; such as plaque, thrombus, and 
regions of tissue compression, (2) incorporating design optimization studies with reversible 
reacting mechanisms, and (3) including modeling the coating and finite drug reservoir, the 
presence of thrombus, or allowing for neighboring or overlapping stents. The latter might require 
the inclusion of luminal flow in the model to achieve the correct delivery patterns. 
For arterial phantom studies, future studies need to capture the effects of local 




studies, although the studies based on 2-D models have revealed some key features in fluid-
structure interaction, there is a need nonetheless to develop three-dimensional models to define 
the physiognomies that only occur in realistic systems.  Three-dimensional models can provide 
insight on realistic issues that occur in blood flow in the arterial network such as non-
axisymmetric buckling of the tube and secondary flow.  There are relatively few theoretical 
investigations of flow in three-dimensional collapsible tubes.  The next chapter presents the 

















3 CHAPTER 3  
Methodology 
In Chapter 3, the measuring tools, flow loop components, design requirements, and 
calibration techniques developed and used in the present study are discussed.  It is important to 
know what a measuring tool cannot do as well as what it can do before a final selection is made.  
Each measuring tool has advantages and disadvantages, and the degree of performance is directly 
related to how well a measuring tool‟s capabilities and shortcomings are matched to the working 
environment and application.  A thorough explanation of the selection of each measuring tool is 
provided in addition to decision matrices which were developed and used as a down selecting 
tool in the design process.  The design requirements for the cardiovascular phantom developed 
for the present study is presented.  The process developed for designing and calibrating the 
phantom flow loop is also presented.  The next section presents a discussion on the design 
requirements and design processes of the pulse duplicator and cardiovascular phantom. 
 
3.1 Cardiovascular Phantom CAD Model Development 
In the present study, an experimental cardiovascular phantom consisting of the major 
arteries that deliver blood from the heart to the head and feet is presented.  The schematic 
presented in Figure 3.1a provides an overview of the major arteries that are modeled in the 
cardiovascular phantom.  The schematic in Figure 3.1b is a CAD model schematic of the 
cardiovascular phantom which was created in Solidworks.  The CAD schematic was used to 
create the mold for fabricating the phantom.  The CAD model presented in Figure 3.1b was also 
used as a geometry mesh for the digital cardiovascular phantom used for CFD simulations which 










(a)  (b) 
 
Figure 3.1. Full cardiovascular system: (a) schematic representation of arterial system, and (b) 
Cardiovascular phantom CAD model. 
 
The CAD model was created from patient-specific CTA scans.  A Matlab code was 
written to upload the CTA scans of each artery, calculate the centroids, and produce surface 
splines at each discrete cross section along the lumen centerline to create the solid geometry.  
The process of generating the CAD model is described in more detail below: 
1. Import the point cloud CTA image. 
2. Calculate the centroids of the arterial fluid core (lumen) contours. 
3. Translate the data so the fluid core is centered at the origin of the coordinate axes. 
1.  Jugular vein  
2.  Subclavian vein  
3.  Aorta   
4.  Pulmonary artery  
5.  Pulmonary veins  
6.  Renal artery  
7.  Mesenteric artery  
8.  Femoral vein   
9.  Popliteal  vein  
10.  Carotid artery  
11.  Subclavian artery   
12.  Superior vena cava  
13.  Hepatic vein  
14.  Inferior vena cava   
15.  Hepatic artery  
16.  Renal vein  
17.  Hepatic Portal vein   
18.  Femoral artery  
19.  Popliteal artery 
20.  Jejunal artery 
21. Coronary artery 










4. Estimate the centerline of the fluid core. 
5. Rotate the data so that the centerline is aligned with coordinate axis. 
6. Calculate the hydraulic diameter of the inlet. 
7. Create surface splines at each cross section along the centroids. 
8. Create a flow extension to ensure fully developed flow. 
9. Export the new coordinates for the lumen cross section to Solidworks. 
10. Unite the surface splines using the boundary boss base feature. 
To align the fluid core with the x-axis, an estimate of the centerline had to be made.  This 
was accomplished using cubic spline interpolation.  The cubic spline produces a smooth 
continuous curve.  Matlab contains in-built functions for implementing cubic splines, however 
the cubic spline method is described below.   
2 3( ) ( ) ( )i i i i i i i iS a b x x c x x d x x
  
        for [ , 1]i ix x x         Eqn. 3.1 
For a spline with “n” centroids, there are n-1 cubic polynomials that have a total of 4n-4 
unknowns.  Continuously constraints account for 2n-2 unknowns: 
( )i i iS x a            Eqn. 3.2a 
1 1( ) ( 1)i i i i iS x S x a            Eqn. 3.2b 
smoothness in the first and second derivatives for the interior curves account or another 2n-4 
unknowns: 
1 1 1 1' ( ) ' ( )i i i iS x S x               Eqn. 3.3a 
1 1 1 1'' ( ) '' ( )i i i iS x S x            Eqn. 3.3b 
The last two constraints are handled in Matlab with the “Not-a-Knot” constraint.  This constraint 






1 2 2''' ( ) ''2( )S x S x          Eqn. 3.4a 
2 2 2 2'' ( ) '' ( )n n n nS x S x            Eqn. 3.4b 
 
with the estimate of the centerline calculated, the geometry data can be rotated to align the fluid 
core with the x-axis.  To rotate the geometry data a rotation matrix had to be constructed.   
Equation 3.5 is a generalized rotation matrix: 
 
2 2
1 1 1 2 3 1 3 2
2 2
1 2 3 2 2 2 3 1
2 2
1 3 2 2 3 1 3 3
(1 ) (1 ) (1 )
(1 ) (1 ) (1 )
(1 ) (1 ) (1 )
u u c u u c u s u u c u s
R u u c u s u u c u u c u s
u u c u s u u c u s u u c
      
 
      
       
    Eqn. 3.5 
where 
cosc            Eqn. 3.6a 
sins            Eqn. 3.6b 
 
and 1 2 3( , , )u u u u  is the axis of rotation and   is the angle of rotation.  In the case of aligning 
the fluid core with the x-axis, u is determined by the cross product between the slope of the 
centerline estimate at the first contour, n

, and the unit vector along the x-axis,  x

.  The angle is 
determined by using the four-quadrant inverse tangent, atan2 function.  This allows for accurate 
calculation of the angle of rotation even when the two vectors are nearly parallel. 
The coordinates of the points from the original CTA point cloud images were defined on 




to have the first contour of the fluid core centered on the origin and the centerlines of the 
geometry were estimated to allow the fluid core inlet to be aligned to the x-axis.  The hydraulic 
diameter of the fluid core was calculated to create the flow extension to ensure fully developed 
flow.  This also allows the application of an unsteady inlet boundary condition.  The hydraulic 






           Eqn. 3.7 
where A is the cross-sectional area and P is the wetted perimeter.  The flow extensions are 0.06 
times the systolic Reynolds number in length.  The method of calculating the Reynolds number 




           Eqn. 3.8 
The entrance length was chosen to allow for a smooth transition to the irregular cross-
section of the arterial lumen during the lofting process and to allow the diffusion of the viscosity.  
The flow extensions also allow the flow to develop to the patient-specific geometry.  The lofting 
process was completed in Solidworks.  The cross-sectional contours along the centerline of the 
model were united using the boundary boss base feature.  The solid CAD model was used to 
create a mold for the cardiovascular phantom.  The CAD model was also used for the digital 
cardiovascular phantom for CFD simulations.  For CFD studies the digital cardiovascular 
phantom was looped such that the phantom had only one inlet and one outlet.  The boundary 
condition for the inlet was an unsteady velocity profile specified by a user defined function (udf).  
The user defined function was used for both regular flow and dye trace studies.  The next section 





3.2 Cardiovascular Phantom Design Fabrication Process 
The design criteria of the phantom and pulse duplicator that was used in the design 
process are listed.  The experimental cardiovascular phantom should: 
1. Be made from a material that can mimic the compliance of the arteries. 
2. Be made from a material that allows flow visualization for dye transport and 
physiological Peclet numbers. 
3. Instrumented such that physiological parameters (flow rate, pressure, wall shear 
stress, and normal stress) can be determined. 
The pulse duplicator should: 
1. Be capable of producing simplified and patient-specific volumetric waveforms. 
2. Be capable of performing user defined physiological parameters (temperature, 
pressure limits, volumetric waveform, and frequency) 
3. Measuring diagnostic parameters. 
The material used to construct the arterial vessels is a clear silicone material that matches 
the elasticity of human arteries and is optically transparent for flow visualization.  The CAD 
model was sent to United Biologics for processing.  United Biologics used a lost casting 
technique to produce the cardiovascular phantom for the present study.  A picture of the 
cardiovascular phantom prior to connecting to the pulse duplicator, flow measuring devices, 
compliance chamber is presented in Figure 3.2.  A decision matrix that was used to select the 






















Figure 3.2. Cardiovascular phantom prior to looping with components. 
 
Common 



































































































The pulse duplicator that was used in the present study is a custom made BDC Labs pulse 
duplicator.  In the present work, the pulse duplicator acts as the pumping heart; therefore with the 
pulse duplicator and the appropriate components, the local hemodynamics of the major arteries 
and vascular bed within the arterial system can be simulated.  The pulse duplicator used in the 
present study is capable of producing physiological data and allowing more user defined 
functionality than previous studies have.  The pulse duplicator is capable of producing simplified 
and patient-specific aortic volumetric waveforms for rest-state and exercise conditions.  The 
maximum systolic volumetric waveform for the present study is 17 L/min.  The pulse duplicator 
is also capable of producing user defined volumetric waveforms with the capabilities of adding 
on harmonic terms for the input waveform.  The pulse duplicator is programmable for 
controlling the temperature of the working fluid, the frequency of the flow (heart rate), 
volumetric flow rate, pressure limits and stroke volume.  The pulse duplicator has its own data 
acquisition software for monitoring real time volumetric flow rate and pressure during 
experimental runs.  The data acquisition software also contains analysis capabilities that allow 
the user to analyze waveforms using techniques such as Fast Fourier Transform of output 
waveforms and signal analysis. 
In addition to producing user defined volumetric waveforms, the pulse duplicator has its 
own in-built compliance chamber for allowing the user to control the compliance of the system.  
The pulse duplicator is a highly repeatable and a controllable pulsatile pump.  A picture of the 
data acquisition used for the pulse duplicator is provided in Figure 3.4.  The next section presents 
the flow meter and pressure measuring devices that were considered for the present study and the 
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3.3 Flow Meter and Pressure Measuring Device Types Considered 
The first flow measuring device that was selected for the present study was a flow meter.  
There are a variety of methods available to measure volumetric flow rate.  Table 3.2 provides a 
list of commonly used flow meter device types that are used in flow applications.  Table 3.3 
presents the decision matrix that was developed and used as the down selecting tool for the flow 
meter device type selection process.  From the decision matrix listed in Table 3.3, a restriction 
flow metering device was deemed to be the most suitable choice for the present study.  The 




Flow meter device types and specifications. 





Dependent on the 
differential pressure 
device 
Nozzle type opening 4:1 Range 




Traversing Methods 0.2 Thermal anemometers 0.38-1000 L/min 
 
Restriction flow meters for internal flow are based on acceleration of a fluid stream 
through a diverging area in which the differential pressure is measured using a pressure 
measuring instrument.  The flow rate can then be inferred using a theoretical analysis or an 
experimental correlation device.  The most popular restriction flow metering devices are orifice 
and Venturi meters.  An orifice meter consists of an orifice plate with a machined hole in the 
center.  The orifice plate is positioned between two straight pipes in length, usually flanged.  




















































































The Bernoulli‟s equation describes the corresponding pressure drop that takes place and 
is also used to correlate the theoretical mass flow rate.  An orifice meter was not used because a 




adapters to achieve the correct pressure drop to correlate a flow rate reading.  As a result, the 
orifice meter is not space accommodating.  The Venturi meter consists of a conical entrance and 
exit section connected by a reduced cross section area in length.  The reduced area section is 
recognized as the throat of the Venturi. 
Similar to the orifice meter, the Venturi meter is also based on the reduction of flow 
pressure accompanied by an increase in velocity.  The pressure drop experienced is used to 
measure the rate of flow through the Venturi meter.  On the discharge side of the meter, the fluid 
velocity is decreased and the original pressure is recovered.  Because of the shape of the Venturi 
element, the pressure losses in a Venturi meter are less than in an orifice meter.  The derivation 
and clarification of the correlation between theoretical mass flow rate and pressure drop can be 
found in (Fox R. 2004).  A Venturi meter was not used because a Venturi meter requires molding 
and casting of the Venturi element.  Hot-wire anemometers is another method used for 
measuring flow rate and is a traversing method.  Hot-wire anemometers were not considered 
because the phantom material is sensitive to heat transfer and will deform and break under 
extensive heat. 
From the decision matrix listed in Table 3.3, a Pasco Spark data acquisition system, with 
single pressure and differential pressure measuring and data capturing capabilities were chosen.  
The Pasco system was used to measure pressure at a point and to measure the volumetric flow 
rate of the pulsatile flow via differential pressure.  An in-house wedge flow meter that was 
constructed from a PVC pipe was used in conjunction with the pasco pressure measuring device.  
The wedge flow meter element operates based on differential pressure.  The spark system is 
factory calibrated to infer a volumetric flow rate reading based on differential pressure for flow 




inbuilt flow meter.  The cardiovascular phantom was connected to a fluid flow loop which 
consisted of a compliance chamber/fluid reservoir, pulse duplicator, two pressure meters (head 
and feet), and a flow meter.  A Tilt table was also installed to test the phantom during transition 
from bed-rest to upright position.  Figure 3.4 shows the phantom connected to the loop. 
 






















3.4 Design of In-house Particle Imaging Velocimetry System 
An in-house PIV system was designed and built for the present study.  As mentioned 
earlier in Chapter 3, PIV consists of capturing images of small spherical hollow glass particulates 
moving with the flow field.  The images are processed using software to determine information 
on the flow such as flow patterns, flow trajectory, and flow parametric data.  The in-house PIV 
system used in the present study consisted of two high speed Basler acA2040-180 km CMOS 
cameras in conjunction with a PIXC1-E8 frame grabber (Epix, Inc.) which captured images of 
the particulates moving with the pulsatile flow field.  Navitar NMV-35M1 lenses are used, which 
have an effective focal length (EFL) of 35 mm.  The lenses have a minimum f-number of 1.4.  
The frame grabber is a Camera Link frame grabber that is able to capture the camera frame rate 
sequence using 1.4 Gbyte/sec burst transfer.  The frame grabber is housed in an IBM Desktop 
computer with a PCI Express x8 79 bus slot and 512 MB of memory.  The sensor and frame 
grabber was controlled using XCAP-Std software (Epix, Inc.) which allowed for sequence 
capture and manipulation of images.  
The pulsatile flow field is illuminated by creating a laser light sheet using a MGH-H-532, 
solid-state green laser (Opto Engine) with a power output of 1.4 W.  A 60° lens is attached to the 
laser as a line generator to create the light sheet.  The laser was operated at a wavelength of 532 
nm which was capable of producing a 1.5 mm thick.  Figure 3.5 provides a photograph of the 
PIV system setup with the laser and cameras.  The in-house PIV system uses open-source PIV 
processing software called PIVlab_1.32.  The code uses time-resolved PIV to pair images and 
calculates the velocity distribution.  The code is also able to derive, display, and export many 










Figure 3.5. Photograph of PIV system (a) and (b) laser and (c) system setup. 
 
Images can be analyzed using either Fast Fourier Transform (FFT) or direct cross correlation 







to conducting any PIV analyses, the PIV system had to be calibrated to insure accurate 
measurements.  The system was calibrated via gravity driven flow and Womersley flow 
(pulsatile flow).  Analytical results were compared to experiments and were found to be within 
3% agreement.  The next section presents the gravity driven flow PIV calibration methodology 
and results. 
 
            3.4.1 Gravity Driven Flow PIV Calibration 
For gravity-driven calibration, a simple, gravity-driven pipe flow problem was setup to 
test the accuracy of the system.  Figure 3.6 shows a CAD schematic of the pipe flow 
experimental setup.  A cylindrical polycarbonate tube (test tube) was used for testing.  The outer 
diameter was 0.19m, inner diameter 0.016m and the length of the pipe was 0.61 m.  The test tube 
was constructed so that the fluid was discharged through a circular orifice, 3.57 mm (9/64”) in 
diameter.  A constant pressure head was maintained to ensure a constant volumetric flow rate.  A 
beaker was used to capture the fluid and a mass balance and stop watch was used to measure the 
mass of the fluid as a function of time to infer a volumetric flow rate measurement.  For 
comparing the PIV results to the analytical solution of gravity-driven pipe flow, the solution had 
to be derived from the Navier Stokes equation.  A simple explanation of the solution is provided 
here.  Assuming one-dimensional (1D) flow, with gravity as the driving force, the parabolic 



















Figure 3.6. CAD Schematic of gravity-driven calibration setup. 













            Eqn. 3.10 

















the point of maximum velocity is found to be at r = 0, or at the centerline of the pipe.  Therefore, 
the maximum velocity is given as: 
max 2V V

           Eqn. 3.12 
The volumetric flow rate in the pipe is equal to the flow rate exiting the orifice due to continuity. 
So the velocity in the pipe can be determined.  Prior to analyzing results, an interrogation 
window and grid step independent study was conducted.  Table 3.4 shows the increments of 
pixel and step sizes used.  The interrogation/grid step sizes were changed in increments of 10 
pixels.  The results were shown to be independent of interrogation area at 64 pixels and 32 pixels 
for grid steps sizes. 
 
Table 3.4 
PIV Interrogation Grid Independent Study. 
Interrogation area [px] Grid (step) size [px] Algorithm Centerline Velocity (m/s) 
44 12 DCC 0.160 
54 22 DCC 0.175 
64 32 DCC 0.180 
74 42 DCC 0.180 
 
Figures 3.7a and 3.7b show the images that were processed in PIVlab_1.32.  Figure 3.7a is the 
first of a series of images that were deployed to be analyzed and b is the resultant vector plot.  
Figure 3.7a shows the PIV results and analytical solution of the gravity driven pipe flow.  Figure 
3.7c displays the contour and vector plot of the measured velocity, which shows the parabolic 




flow problem and is evident in the results.  Figure 3.8 shows the comparison of the analytical and 
the experimental solution.  The results are within 3 percent agreement.  From Figure 3.8, it is 
shown that the largest contribution to error is at the wall were the reflection of the laser light 
distorts the image.  However the no-slip condition is known to take place at the wall of the tube 
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Figure 3.8. Calibration plot of gravity-driven flow with analytical and experimental solution. 
 
            3.4.2 Womersley Flow PIV Calibration 
For comparing the PIV results to the analytical solution of Womersley flow, the solution 
had to be derived from the Navier Stokes equation in cylindrical coordinates.  A simple 
explanation of the solution is provided here.  The flow is assumed to be 1-D flow, with an 











    
         Eqn. 3.13 
where n is the number of harmonics, an is the amplitude, j is an imaginary number, n is the 




driving force and through much manipulation, the velocity profile (analytical solution) can be 
written as a harmonic series equation as a function of radius and time: 
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     Eqn. 3.15 
the solution applies to the results of each harmonic.  To find the velocity as a function of radius r 
and time t for the entire driving pressure, the steady flow (Pousellie flow) result uo is added to 
the results for all harmonics.  For the present study shear stress is a major parameter of interest.  
The shear stress can be found from: 
1
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       Eqn. 3.16 
To expand the form of the shear stress equation the derivative terms are needed: 
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          Eqn. 3.17 
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       Eqn. 3.18 
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For pulsatile experiment calibration, the frequency of the flow was 70 beats per minutes 
(1.2 hertz), maximum systolic pressure of 90 mmHg, and a maximum flow velocity of 0.45 m/s.  
Figure 3.9 shows the measured velocity and pressure profile.  The velocity and pressure was not 
measured at the same point.  The captured data is for 4 cycles.  Figure 3.10 shows the experiment 











































The experimental and Womersley velocity profile centerline velocity (maximum velocity) were 
shown to be within 3 percent difference in error.  Similar to the gravity driven results, the 
maximum error was found to be at the wall.  The results shown are for one cross-section along 
the longitudinal direction (z-direction) of the pipe.  A more detailed analysis is needed to 
determine if the Womersley solution is valid along the longitudinal direction of the pipe.  Figure 




    










Figure 3.11. PIV velocity contour profiles at: (a) 3.0s, (b) 3.1s, (c) 3.2s, (d) 3.3s, (e) 3.4s, (f) 




The results for each time step shows that the flow is not symmetric along the centerline.  For this 
particular case it is important to introduce the Womersley number.  The Womersley number is 




            Eqn. 3.20 
In the case of Womersley flow, if the Womersley number is large (greater than 10) and R is 
larger, the flow is dominated by unsteadiness.  If the radius of the tube is small, then 
unsteadiness is not important and the flow is viscous.  For the present study, the Womersley 
















      Eqn. 3.21 
This calculation indicates that unsteadiness is dominant.  When unsteadiness is dominant in 
pulsatile flow, the centerline velocity oscillates out of phase with the pressure gradient.  Also, 
when unsteadiness is present in the system, this means that the velocity profile is not parabolic at 
each time step in the cycle.  In addition, the velocity profile will not be constant at each cross-
section along the axial direction of the pipe.  In summary, non-symmetric flow will be present in 
the case of unsteady flow.  Figure 3.12 provides contour plots and centerline data for the PIV 
results.  Figure 3.12 provides a clear representation of non-symmetric velocity profile at each 
discrete time interval.  Figures 3.13a 3.13b and 3.13c also show how the velocity at each discrete 
cross-section along the axial direction of the pipe is not constant.  This is due to the unsteadiness 
of the system in which the Womersley solution cannot be applied.  The Womersly solution 
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(e) 
Figure 3.12. Experimental centerline velocity profile. 
 From the results shown in Figure 3.12e, at times 3.0 and 3.2 the results change in 
magnitudes slightly and maintain the same trend in profile.  However at time 3.5, the profile 




Wormersley solution is only valid for small Womersley numbers or viscous flows.  This because 







Figure 3.13. Experimental and computational velocity profile comparisons at(a) 4.3s, (b) 3.7s (c) 
3.9s and(d)  4.0s 
 
Figure 3.13 shows a comparison of the computational and experimental velocity profiles at each 
time step.  The time steps chosen were time steps that were below transition time as shown in 




no longer agree.  As shown in Figure 3.13, the maximum error tends to be near the wall.  This 
error is due to the harmonics present in the system and the distortion of the light sheet entering 
the conduit from the laser. 
3.5 Dye Mass Concentration Methodology 
For the present study, a dye mass concentration study was conducted on the phantom.  
The dye mass concentration methodology consists of measuring the dye front of the fluid.  A 
time dependent point measurement can be taken at any point on the phantom.  A detailed 
overview of this is provided in Chapter 4.  However the methodology is discussed here.  The dye 
mass concentration method is conducted via optical measurements using a standard LED light 
and CMOS camera system.  The same camera system from the PIV system is used.  The 






          Eqn. 3.21 
Prior to collecting any mass concentration measurements of the dye, the system setup had to be 
calibrated.  The calibration consisted of creating known concentrations of the fluid (water) to dye 
and measuring the intensity.  A Matlab script file was written to measure the intensity of images.  
The intensity could then infer a concentration measurement.  It is assumed that both the ratio of 
initial intensity to indexed intensity is proportional to the ratio of initial concentration to indexed 
concentration as shown below: 
0 0I C
I C
           Eqn. 3.22 
The intensity script written in Matlab collects the images and converts the image to a 
scaled grey image of 256 levels of gray.  The 256 level of gray (all white) is considered to be the 




concentration (black).   Figure 3.14 shows the test tube with a concentration of dye to water and 
the LED light used.  The script creates a measurement line across the tube and measures the 
average intensity across the diameter of the test tube.  The test tube is made of the same material 
as the phantom so that an accurate mass concentration measurement could be made. 
 




Figure 3.14. Dye Mass Concentration apparatus setup: (a) LED light of with a known mass 
concentration in fluid and (b) Light on with known mass concentration. 
 
Eight mass concentrations were made ranging from 0 to 1.  Each mass concentration was 
converted to intensity and a calibration plot was generated.  The calibration plot of the 
Concentration vs. Intensity is shown in Figure 3.15.  The calibration equation is shown and the R 
value for the line of best fit is 0.9975.  The next section presents the stent geometry generation 
methodology for CFD. 





Figure 3.15. Calibration plot of Dye Mass Concentration setup. 
 
3.6 Stent Geometry Modeling and CFD Modeling Methodology 
The three in-house stent design patterns evaluated in the present work are similar to stents 
manufactured by Abbott Laboratories (Abbott Park, Illinois, U.S.A.) and Biosensors (Europe, 
SA (BESA), Switzerland).  The geometric details of each stent are provided in Table 3.5.  To 
make a design comparison, representative geometries for each stent are constructed with the 
same strut: diameter (5 mm), length (24 mm), and thickness (0.24 mm).  The  strut spacing 
for each stent design evaluated is representative and differs to some extent from commercially 
available stent designs.  Figure 3.16 shows the flattened out geometries for the three in house 




The flattened geometry was sketched on a plane, extruded to the required thickness, and then 
converted to a circular meshed tube (stent) using a wrap feature.  For CFD simulations in the 





Geometric details of stent models. 
Model label A B C 
Number of Columns 10 10 10 
Number of Struts 42 10 72 
Outer diameter  5 mm 5 mm 5 mm 
Strut thickness  0.24 mm 0.24 mm 0.24 mm 
Length 20.25 mm 20.25 mm 20.25 mm 
Aspect Ratio (e/d) 0.048 0.048 0.048 
Aspect Ratio (e/L) 0.012 0.012 0.012 
Aspect Ratio (d/L) 0.250 0.250 0.250 
 
The physiological assumptions used in the present work has also been used in the work of 
(Siauw, Ng et al. 2000; Zhao, Ariff et al. 2002; Farmakis, Soulis et al. 2004; Giannoglou, Soulis 
et al. 2005; Cheung, Wong et al. 2010).  Blood is modeled by the incompressible Navier-Stokes 
equations with blood density specified as 1060 kg/m
3
 and the corresponding kinematic viscosity 
0.0032 m
2
/s.  The commercial software ANSYS was used for geometric meshing and 
FLUENT
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Figure 3.16. Stent designs used for the present study. 
Numerical simulations were performed for simplified arterial stented cores and patient-
specific arterial stented cores.  Figure 3.17 shows the simplified arterial stented cores and 
patient-specific arterial cores that were evaluated in the present work.  The simplified arterial 




in Figure 17b.  The patient-specific stented core consisted of an arterial geometry obtained from 
a computed angiographic (CT) scan of a 50 year old male as shown in Figure 16c.  The image 
contained a point cloud, which defines the surface geometry of the carotid bifurcation by discrete 
domains.  The image was processed in CAD software called Solidworks using a curve creation 
feature.  The curve creation feature united the point cloud with 3-D surface splines.  This 
technique was repeated at each domain until the entire arterial geometry was defined.   Each 3-D 
spline domain was then united using a lofting and boundary boss feature until the final solid 
product was obtained.  This process is outlined in (Hewlin and Kizito 2011).  The arterial wall at 
the stented region for both the simplified arterial stented core and the patient-specific arterial 
stented core is straight with constant diameter. 
 
 
Figure 3.17. Arterial stented fluid cores evaluated for the present study. 
The three dimensional stented regions were created in Solidworks with a solid cylinder 




geometry represents full strut exposure to the blood flow.  The stent geometry and the solid 
cylinder were united using the mating feature then removed using a Boolean operator in which 
the geometry of the stent is removed from the cylinder and the stent geometry impression 
remains in the cylinder.  The models are discretized and used as computational domains.  Grid 
meshing levels were performed at three levels: coarse (132,226), coarse (155,998) and medium 
(306,085).  A sinusoidal velocity waveform boundary condition was specified at the inlet and the 
outlet(s) was modeled as pressure outlets at 12 kPa (90 mmHg).  The No-slip boundary 
conditions were imposed at the walls.  The flow velocity amplitude in the inlet of each stented 
core was set to 0.2 m/s and a heart rate of 168 beats/min (2.8 Hz) to simulate normal cardiac 
behavior.  The comparison of the velocity magnitude at the ICA for arterial stented core 
geometric models resulted in a 0.32% difference in velocity in a grid independence study.  With 
such a small difference, simulation results were independent of the computational mesh when the 
disparity between mesh spacing varying densities was less than 1%.  For numerical solutions, the 
velocity coupling solving technique was implemented.  Table 3.6 presents the grid independent 
study. 
Table 3.6 
Arterial geometry mesh independent study data. 
Number of Cells Wall Shear Velocity Pressure 
104,406 15 Pa 1.2 m/s 99 mmHg 
143,948 8.3 Pa 0.51 m/s 90 mmHg 
233,045 8 Pa 0.5 m/s 90 mmHg 
 
The WSS, normal stresses, and vorticity values are predicted on fluid domain surfaces that 




3.18 shows the stented core unit cell schematic and geometric data of each stent design.  The 
next section presents the DES drug concentration study methodology. 
 
Figure 3.18. Stent Unit cell specifications. 
3.7 DES Drug Concentration Study Methodology 
Solidworks was used to model the stent deployment to the vessel wall.  A schematic of 
the artery wall and stent impression is shown in Figure 3.19a.  In the present study, a transmural 




as a porous media.  The Darcy Law model was used to solve the plasma flow field.  Fluent 
implements the Darcy Law equation as a source term in the Navier-Stokes equations: 





       
 
       Eqn. 3.23 
where c is the velocity vector, P is the pressure, K is the permeability of the vessel wall, and are 
the density and viscosity of plasma.  The density of plasma is 1.02 g/cm
3
 and the viscosity is 
0.012 g/cm s.  The permeability of the plasma wall was set at 2.0E-18m
2
. 
The arterial wall concentration profile was not solved in conjunction with fluid flow 
analyses.   Instead, the models were solved separately.  This introduces an assumption because 
the flow decreases axial non-uniformity of the drug in the artery wall.  The degree of non-
uniformity is observed to increase with increasing aspect ratio of stent struts.  The impact of the 
assumption is minimized by the use of square struts with an abluminal coating which is the case 
used in the present study. 
3.7.1 Boundary Condition for Drug Transport 
The boundary conditions for each zone are provided in Figure 3.19.  The „„plasma 
velocity inlets‟‟ zone represents the exposed inner surfaces of the artery.  The „„stent 
impression‟‟ represents the location where the stent is in contact with the vessel wall.  The rest of 
the surfaces shown in Figure 3.19 are treated as symmetry planes.  For the velocity inlets, a 
component (x,y,z) velocity inlet is specified.  The normal velocity component (vn) was set equal 
to 1.0E-8 m/s. The tangential velocity components were set equal to zero on the „„velocity 













Drug deposition boundary 
Symmetry boundary condition 





3.7.2 Formulation of the Drug Transport Model 
For the Drug transport problem, the vessel tissue was modeled as a composite material, 
one unbound and bound.  The bound material is a collection of drug binding sites, and the 
unbound compartment as the neighboring constituents.  Each material is a homogeneous 
material.  The elution process is modeled such that the drug diffuses out of the stent coating into 
the plasma and then partitions into and out of the drug binding site compartment.  A two-species 
model was used to account for the two materials and the partitioning of the drug between the two 
materials.  The free transport of the drug into the unbound material which is referred to as Cu.  
The restrained drug is referred to as the bound drug, denoted Cb.  The inter-conversion between 
the unbound plasma phase and the bound phase of tissue binding sites is controlled via an 





C C           Eqn. 3.24 
Where kf is the forward reaction rate and kr is the reverse reaction rate, Keq is the equilibrium 
coefficient which is equal to the ratio of the forward and reverse reaction.  The affinity drug for 
the plasma phase decreases as keq increases.  The reaction rate R between the bound an unbound 
form is: 
f u r bR k C k C           Eqn. 3.25 
The unbound drug is subject to transport by plasma flow, diffusion, and reaction.   The transport 
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where Du is the diffusion tensor for the unbound drug.  The unbound drug was assumed to by 
completely immobilized in the tissue.  This was accompanied by setting v=0, which leads to the 









         Eqn. 3.27 
where Db is the diffusion tensor for bound drug.  The contribution of the diffusion term was 
minimized by setting Db=1.e-7Du.  
 
3.7.3 Initial and Boundary Condition for the Drug Transport Model: 
The arterial wall was assumed to have no drug present at the time of stent implantation, 
therefore the concentration at the wall was set to zero.  The boundary conditions for the model 
were:  
, 1u stentC            Eqn. 3.28 
















         Eqn. 3.31 
The zero concentration of drug at the lumen assumes a continuous supply of drug in the stent 
coating.  This is probably the most unrealistic of the applied boundary conditions as it is typical 
for the drug to be depleted after 1–3 months.  The zero concentration of drug at the lumen also 
assumes that the drug concentration in the blood is negligible.  Eqn. 3.30 is a symmetry 
condition and Eqn. 3.31 assumes that the convective flux is the dominant transport mechanism at 




the convective and diffusive components were assumed to be negligible for this drug form.  The 























4 CHAPTER 4 
Results 
4.1 Cardiovascular Phantom Posture Transition Studies 
In this section, the present study addresses the cardio- and cerebrovascular responses to 
the everyday orthostatic challenge of moving from bed rest to upright standing position.  The 
vascular pressure change (cerebral and femoral) profiles that occur doing a transition from bed 
rest to an upright position on the cardiovascular phantom is discussed.  The age range of the 
simulated subject (cardiovascular phantom) is 28-40 years of age.  The most prominent condition 
that is accelerated and progressed by an accelerated change in posture is orthostatic hypotension 
and intolerance.  The results discussed are addressed to provide insight on the magnitude of 
vascular pressure changes and the types of parametric profiles that exist during a transition from 
bed rest to upright position. 
Orthostatic intolerance is a broad term used for several conditions characterized by 
symptoms of light headedness, dizziness and faintness on assuming upright posture.  The 
underlying mechanism of orthostatic intolerance is the inability of the autonomic nervous system 
to maintain adequate hemodynamic behavior of the body during upright posture resulting in 
cerebral hypoperfusion which leads to its symptoms.  Upright posture is the most physiological 
orthostatic stressor and it imposes stress leading to gravitational pooling of blood in the 
splanchnic venous reservoir and leg veins.  On standing 300 to 500 ml of blood is forced 
downward to the abdominal area and lower extremities.  A healthy subject is able to reach 
orthostatic stabilization in 60 seconds or less by an increase in sympathetic outflow resulting in 
vasoconstriction of capacitance and arteriolar vessels.  However, in patients with orthostatic 




nervous system leads to decreased vascular tone, heart rate and cardiac output with resultant 
acute cerebral hypo perfusion.  Normally a reproducible cardiovascular reactivity (CVR) pattern 
mediated via autonomic nervous system results in slight increase 10–15 bpm in heart rate and 
blood pressure 10–15 mmHg (1.33-2 kPa) to balance the situation.  When autonomic nervous 
system is dysfunctional normal CVR pattern is altered so that blood pressure is not maintained at 
adequate levels during upright posture resulting in cerebral hypo perfusion and symptoms of 
orthostatic intolerance. 
In the absence of volume depletion, younger patients with orthostatic hypotension usually 
have chronic autonomic failure.  A related problem, postprandial hypotension, is common in 
older patients and those with autonomic dysfunction.  In postprandial hypotension, there is a 
decrease in systolic blood pressure of at least 20 mmHg (2.7 kPa) within 75 minutes of a meal.   
A normal hemodynamic response to changes in posture requires normal function of the 
cardiovascular and autonomic nervous systems.  Standing results in blood pooling of 
approximately 500 to 1,000 mL in the lower extremities and splanchnic circulation.  This 
initiates an increase in sympathetic outflow, which increases peripheral vascular resistance, 
venous return, and cardiac output, thereby limiting the decrease in blood pressure.  These 
compensatory mechanisms result in a decrease in systolic blood pressure 5 to 10 mmHg (0.67-
1.33 kPa), an increase in diastolic blood pressure 5 to 10 mmHg (0.67-1.33 kPa), and an increase 
in pulse rate (10 to 25 bpm).  However, orthostatic hypotension may result if there is inadequate 
intravascular volume, autonomic nervous system dysfunction, decreased venous return, or 
inability to increase cardiac output in response to postural changes.  Decreased cerebral perfusion 




Figure 4.1 presents a plot of the scaled hemodynamic flow parametric flow profiles.  The 
flow profiles are scaled and plotted on the same graph to show that a time lag exists between the 
profiles.  The volumetric flow rate waveform is scaled with the maximum flow rate, which is the 
flow rate at systole and the pressure waveform is scaled with the maximum pressure at systole.  
As shown in Figure 4.1, there is a time lag from the systolic peak of the pressure waveform to 
the systolic peak of the flow rate wave form (peak to peak) at 0s, 1s, 2s, and 3s.  However, the 
time lag at 1s is different between the time lag at 1s, 2s and 3s.  This may be due to some 
abnormality during startup or during data capturing.  The time lag between the profiles is at 
systolic peaks is 0.3s, and 0.5s at diastolic peaks.  This is due the pulsatile pressure being the 
driver of the flow and the flow rate being the response.  Also in the present study, a static trial 
was conducted to measure the pressure change from cerebral (head) to femoral (feet) during bed 
rest (lying down) and upright (standing up).   
 
 
Figure 4.1. Static parametric flow profiles: (a) unscaled volumetric flow rate, and (b) scaled 












Figure 4.2. Static trial run pressure results for: (a) lying down and (b) standing up (upright). 
 
Two heart rates were evaluated (60 and 65 bpm) to simulate rest state (normal heart rate) 
and semi-exercise (accelerated heart rate).  Figure 4.2 provides a plot of pressure changes from 




down position and during rest state cycle, the head systolic pressure is 14 kPa (105 mmHg) and 
the head diastolic pressure is 2 kPa (15 mmHg).  During the semi-exercise (accelerated heart 
rate) cycle and lying down, head systolic pressure is 17.2 kPa (129 mmHg) and head diastolic 
pressure is 5.8 kPa (43.5 mmHg).  During the lying down position and during rest state cycle, 
feet systolic pressure is 10.2 kPa (76.5 mmHg) and the feet diastolic pressure is 5.4 kPa (40.5 
mmHg).  During the semi-exercise (accelerated heart rate) cycle and lying down, head systolic 
pressure is 17.2 kPa (129 mmHg) and head diastolic pressure is 5.8 kPa (43.5 mmHg).  For 
upright position and during rest state, the head systolic pressure is 10.4 kPa (78 mmHg) and the 
diastolic head pressure is 0 kPa (0 mmHg).  During the semi-exercise cycle and in the upright 
position, the systolic head pressure is 14.8 kPa (111 mmHg) and the diastolic head pressure is 
2.5 kPa (18.8 mmHg).  The feet systolic pressure during upright position and during rest state 
was found to be 1kPa (7.5 mm Hg) and diastolic pressure was -5 kPa (-37.5 mmHg).  The feet 
systolic pressure during upright semi-exercise 3 kPa (22.5 mmHg) and diastolic pressure is -4 
kPa (-30 mmHg). 
A more generalized statement is that the pressure difference from systolic to diastolic is 
approximately 12 kPa (90 mmHg) during rest state cycle and exercise, whereas the feet systolic 
to diastolic pressure difference during rest state and exercise is approximately 5 kPa (37.5 
mmHg).  The systolic pressure difference from head to feet during rest state and lying down is 4 
kPa (30 mmHg) and the systolic pressure difference during rest state and upright is 9 kPa (67.5 
mmHg).  The pressure cycles show a shift in time phase between heart rates.  The phase shift in 
head pressure 0.25 seconds and the phase shift for feet pressure are 0.2 seconds.  The pressure 
difference between head and feet is important because it gives insight on the level of blood return 




Pressure difference is also important when considering accelerated movement from bed rest to 
upright position.  This pressure difference is referred to as blood pooling.  Because of this 
pooling, the amount of blood carried back to the heart by the veins is decreased.  Subsequently, 
less blood is pumped out from the heart, resulting in a sudden drop in blood pressure.  By 
definition, the drop in blood pressure must be greater than 2.6 kPa (20 mmHg) during 
contraction of the heart muscles (systole) and more than 10 mm of mercury during expansion of 
the heart muscles (diastole).  Normally, specialized cells in the body (baroreceptors) quickly 
respond to changes in blood pressure.  These baroreceptors then activate the autonomic nervous 
system to increase, via reflex action, and increase levels of catecholamines (e.g. epinephrine, 
norepinephrine) in the body.  Increased catecholamine levels rapidly restore the blood pressure.  
A defect in this spontaneous response (reflex) prevents the heart rate and blood pressure from 
rising adequately and orthostatic hypotension results. 
Figure 4.3 shows a plot of the pressure cycle profiles during transition from bed rest to 
upright position.  The two pressure cycle profiles simulate two scenarios, an atherosclerotic 
diseased stenosis at the ascending aorta (stenosed at 42%) and a hypertension stage 1 patient.  
Table 4.1 provides an outline of the stages of hypertension and the analogous hemodynamic 
conditions.  
Table 4.1 
Orthostatic hypertension blood pressure assessment.   
 
Systolic Blood Pressure Diastolic Blood Pressure Assessment 
Below 120 Below 80 Normal 
120-139 80-89 Prehypertension 
Over 140-159 90-99 Hypertension Stage 1 




From Figure 4.3, the hypertension stage 1 pressure cycle has a maximum systolic pressure of 
approximately 136 mmHg in the time range of 3.7 seconds.  After 3.7 seconds the phantom is 
transition to bed rest to upright position and the systolic head pressure changes to 126 mmHg 
(16.8 kPa) at and 124 mmHg at (16.5 kPa) and stabilizes to 120 mmHg (12 kPa).  For the 
stenosis case, the maximum head pressure is at 159 mmHg (21.2 kPa) in the range of 3.7 
seconds.  After 2.4 seconds, the pressure spikes to 163 mmHg (21.7 kPa) at 3.44 seconds and 
151 mmHg (20.1 kPa) 4.4s and then 149 mmHg (19.9 kPa) at 5.4s and then stabilizes to 145 
mmHg (19.33 kPa).  From the static condition mentioned previously and referring to Figure 4.1, 
the maximum pressure is 70 mmHg (9.33 kPa) for normal conditions in the upright position.  A 
comparison can be made between normal, stage 1 hypertension and a 42% stenosis case.  
The transition pressure difference for normal and stage 1 hypertension is 66 mmHg (8.8 
kPa) and the stabilized pressure difference is also 50 mmHg.  The most notable difference (6.7 
kPa) is the pressure difference during the maximum pressure and transition pressure.  The 
transition pressure has to be greater than 2.6 mmHg (0.35 kPa) to avoid blackout.  The transition 
pressure for stage 1 hypertension is 2 mmHg (0.27 kPa) and the transition pressure for the 
stenosed case is 1 mmHg after the spike in pressure during the transition.  For both cases the 
phantom produces hemodynamic data which suggest the patient will be subject to blackout 
during posture changes.  In terms of pressure head, the pressure head is higher when the phantom 
is in bed rest position as oppose to upright position.  The reason that the pressure is higher during 
bed rest position is because the pump produces less work when gravity is negligible.  The 
pressure head is calculated using the density, gravity, and height.  When the pump is working 






Figure 4.3. Posture transition pressure cycles at. 
 
Figure 4.3 present the transition pressure for several cases of stenosis.  In Figure 4.3, it is shown 
that for a normal case the maximum transition pressure is 120 mmHg (16 kPa) and for the 
stenosis case presented earlier (42% stenosis), the pressure is 151 mmHg (20.1 kPa).  For an 
extremely severe case, the maximum transition pressure is 170 mmHg.  Figure 4.3 is useful in 
the sense that it provides insight of the magnitude of transition pressure that occurs for each 
stenosis case.  Data shown in 4.3 can provide useful information to interventionist that aim to 






Figure 4.4. Pressure change versus percent stenosis. 
 
A general conclusion from the data mentioned is that stage 1 hypertension occurs at 40% 
stenosis and the onset of blackout occurs within this regime.  The next section of the present 
study presents a study on the transfer of dye in the cardiovascular phantom. 
 
4.2 Cardiovascular Phantom Dye Mass Concentration Studies 
In the present study, a dye mass concentration study was performed on the ascending 
aorta of the experimental cardiovascular phantom.  The transport of dye mass in the present 
study is performed to simulate the transport of an injected medical drug (intravenous drug 
delivery/intra-arterial drug delivery).  Intravenous injection involves injecting the aqueous form 
of a drug into a superficial vein or continuous infusion via a needle or a catheter placed in an 
artery or deep vein.  This is the only method of administration available for some drugs and is 




Theoretically, none of the drug is lost, and smaller doses are required other than with other routes 
of administration.  The rate of injection can be controlled for prolonged and continuous 
administration.  Intra-arterial involves direct injection into the arteries and is not a usual route for 
therapeutic drug administration.  Arterial puncture and injection of contrast material has been 
carried out for angiography.  Most of the intra-arterial injections or arterial perfusions via 
catheters placed in the artery for regional chemotheratpy of some organs and limbs.  Intra-arterial 
drug delivers is mostly used for the treatment of malignant tumors of the brain.  Although the 
goal of the present study is centered towards cardiovascular disease and not cancer, dye transport 
is important in cases of cardiovascular disease such as the erosion of a medical drug coating from 
a stent, the deposition and transport of plaque in the cardiovascular system, and the transport of a 
x-ray dye into the cardiovascular system to map out blood flow trajectory paths. 
The present study determined the transit time of the dye front, the axial physiological 
Peclet numbers, and the validity of using numerical experiments as a surrogate for experimental 
setups.  The physiological Peclet number provides information on convective and diffusive 
dominance.  As mentioned previously mentioned in Chapter 3, the dye mass concentration 
methodology consists of illuminating a section of the tubing with a green LED light and filming 
the time the dye front enters the illuminated area.  For the purpose of comparing the 
experimental mass concentration dye transit times to numerical transit time plots for validity, a 
digital cardiovascular phantom was constructed using the same CAD model used to construct the 
experimental cardiovascular phantom for numerical analyses.  A schematic of the digital 







Figure 4.5. CAD schematic of the digital cardiovascular phantom. 
 
During experimental observation, the illuminated section or region of interest (ROA) of the aorta 
appears to be pure water at the time 0s through about 13s.  At approximately 13s, the dye front 
approaches the ROA around.  For visual purposes, the zero mass concentration time was not 
included in the mass concentration.  Figure 4.6 provides a more accurate assessment of the 
transit time of the dye front.  From the time the dye front reaches the ROA, the trend of the graph 
grows exponentially.  The mass concentration is calculated using Eqn. from Chapter 3.  The 
digital cardiovascular phantom contained one inlet and one outlet and a mirrored boundary 
condition was imposed to simulate a closed loop system.  The drug material properties in the dye 
trace study were set to have the same diffusive properties as a water-in-water solution to simulate 















Figure 4.6. Photograph of LED illuminated aortic section for dye mass concentration analysis at: 




Figure 4.7 provides a plot of the mass concentration vs. time.  From 0s until 4s the ROA 
increases in concentration until it stabilizes at 4s throughout the duration of continuous injection.  
Based on normal heart rate and bed rest conditions the transit time for the drug to reach the 
descending aorta is 14s when including the time of injection.  The physiological Peclet number is 




           Eqn. 4.1 





/s.  The maximum Peclet number (systole) is 20,000,000 whereas the 
minimum Peclet number is 400,000 (diastole).  The physiological Peclet number provides insight 
on the balance of convection to diffusion. 
 
 
Figure 4.7. Plot of mass concentration vs. transit time. 
 
CNumerical=0.0389t5-0.4158t4+1.6637t3-3.068t2+2.6423t-0.0685 




 Figure 4.8 provides a numerical vector and contour plot of the velocity at the section 
where the numerical mass concentration profile was obtained.  A plane was sliced in mid-section 
of the descending aorta where the mass concentration measurements were obtained to view the 
magnitude of velocity and provide an explanation of the monotonic behavior/trend in the plot.  
Figure 4.8a provides a vector plot of the velocity at diastole of the cardiac cycle.  The velocity is 
scaled from 0 to 0.122 m/s in terms of radial velocity.  From Figure 4.8a, the direction of the 
flow points to the outward radial direction and the highest flow occurs in regions near the wall 







     
                            (a) 
 
       
(b) 
Figure 4.8. Aorta cross-sectional view of: (a) velocity vectors (left) and velocity contour (right) 






Also from Figure 4.8, the `highest velocity occurs at the peak and near the wall.  Figure 4.9 
provides a snapshot of the vorticity at the cross-section of the aorta.  Vorticity is defined as the 
magnitude of the spin of the fluid. An explanation of how vorticity is calculated is provided.  The 
derivation of the vorticity equation begins with the Navier-Stokes equations in vector form: 
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       Eqn. 4.2 
By taking the curl of the Navier-Stokes equations, the vorticity equation can be obtained.  In 
detail and taking into account u 
 
  , the following is obtained: 
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        Eqn. 4.4 
In the same manner the last term on the right side becomes: 
2 2( )V  
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             Eqn 4.5 
Applying the identity 0s  , where s is a scalar, the pressure term cancels, provided that 
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The inertia term V V
 
 , can be rewritten as: 
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   , and then the second term on the left side can be rewritten as: 
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From Figure 4.9 the highest amount of vorticity occurs during diastole, at which could be due to 
the dampening of the flow.  However, at both systole and diastole the highest vorticity occurs at 
















The experimental results have been compared to the experimental results for validation purposes.  
The key take away from the dye trace study is the experimental and numerical results are within 
3 percent agreement (0.3-1s and 1.7-2s) and that the monotonic behaviors of the mass 
concentration profiles are due to flow reversals.  The study above is a direct simulation of intra-
arterial injection where a catheter is placed in the artery.  Figure 4.10 provides a contour plot at 
discrete time intervals to provide an illustration of the drug trajectory path and transit time during 
the cardiac cycle.  
From Figure 4.10, the dye enters the ascending aorta through the aortic valve at time 
t=0.0s.  The flow appears to be purely convective.  The parameter that describes the convective 
dominance of the flow is the Peclet number.  The Peclet number equation is described earlier in 
Eqn 4.1.  The minimum Peclet number for the flow is whereas the maximum is.  The minimum 
and maximum Peclet number is described by the peak of the cardiac cycle.  From Figure 4.10, 
after the dye enters the aorta, the dye reaches the descending aorta around 4.5s and then reaches 
the femoral section around 11.6s.  The dye does not start traveling up the common carotid artery 
until around 29.6s.  Ultimately, the flow of the dye is focused from the aorta to the femoral 
section.  The flow diverts later into the branching networks after flow has reached the femoral 
sections.  This is important because if a drug is injected into the cardiovascular system and has a 
specific target sight, it is important to know where the drug will go and how much of that drug 
will divert.  Also as shown in Figure 4.10, the time that it takes for the dye to enter the upper 
(cranial) part of the phantom is much longer than it take for the dye to travel around the aorta to 
the descending aorta.  This is due to the centripetal forces that occur around the bend of the aorta.  




shown in the monotonic trend of the mass concentration curve and the rapid transport of dye to 
the descending aorta. 
 
 
   
(a) (b) (c) 
   
(d) (e) (f) 
  
(g)                  (h) 
Figure 4.10. Dye mass concentration at time: (a) t=1.75s (b) t=2.1s, (c) t=4.5s (d) t=11.6s (e) 
t=15.1s (f) t=29.6s (g) t=94.6s, and (h) t=150s.  
Mass Concentration 




Clinical studies may find studies such as these useful to find approximate time frames of drug 
delivery and the trajectory path of the drug from the point of injection.  Due to the fact that in the 
cardiovascular system there are many curves and bends that the drug can take route to, clinicians 
may need to know where exactly the drug may go after injection.  Another study that may find 
this useful is medical implants that disperse drugs into the arterial system.  The next section 
presents a study on the aorta and carotid artery using particle imaging velocimety (PIV). 
 
4.3 Aorta and Carotid Artery PIV Studies 
The present study also examines the hemodynamic parameters of flow in the aorta and 
carotid artery during rest cycle using PIV.  The aorta and carotid artery geometry was 
reconstructed using the same process outlined in Chapter 3.  The geometry used to construct the 
aorta and carotid artery part of the phantom is from a 28 year old patient.  The purpose of this 
section is to address the flow patterns and magnitude of wall shear stress present in the aortic 
section during the rest state cycle.  The carotid artery is branched from the CCA branch of the 
aorta.  Although the geometry used is from a 28 year old patient, the geometry can be modified 
to simulate diseased and non-diseased cases as shown in the previous section.  The aortic section 
of the cardiovascular system is considered to be the main branch/vessel responsible for 
delivering blood to the entire cardiovascular system.  In most cases, the aorta is the first section 
that experiences a buildup of plaque and/or rupture.  The buildup of plaque in any artery reduces 
blood flow throughout the system which in turns reduces the level of oxygenated blood to the 
brain.  Aortic rupture or aneurysm is also another effect of plaque buildup.  Aortic aneurysm is a 
pathological enlargement of the aorta area taking the fusiform shape and may extend to 




ruptured aneurysms), and the current standard of determining rupture risk is based on 
anteposterior diameter.  The high increase of wall shear stress also plays an important role in the 
health of arteries and cardiovascular system.  High levels of wall shear can lead to blood cell 
lysising or endothelial rupturing.  Extremely low levels of wall shear can lead to endothelial cell 
death.  The study begins with flow in the carotid artery.  Figure 4.11 present an image of 
particulates dispersed in the flow through the carotid artery for PIV analysis.  The arterial model 
shown is a glass model and the analyses are conducted from a single unit rather than from a full 
cardiovascular system. 
 
Figure 4.11. Photograph of particulates dispersed in carotid artery flow field. 
 
Figure 4.12 presents the velocity contours at 3.2 s and 3.5 s.  As shown in Figure 4.12, the 
highest magnitude of velocity is present in the bifurcating region of the CCA.  There are also 
period where the flow dampens and accelerates which is due to the fluctuations and harmonics 












Figure 4.12. PIV carotid artery velocity contour plots at time: (a) 3.2 and  (b) 3.5s 
 
Figure 4.12 presents the velocity waveforms of the carotid artery during rest state cycle at 3.2 
and 3.5s.  Figure 4.12a presents the velocity waveform at 3.2s and Figure 4.12b at 3.5s.  The 








Figure 4.13. Carotid artery velocity waveforms extracted from PIV experiments at: (a) t=3.2s 
and (b) t=3.5s.  
 
As shown in both Figure 4.13a and 4.13b, the no slip condition is not captured due to the glare in 
the wall from the PIV lighting.  The hemodynamic parametric results of the aortic section of the 




of the aorta.  The contour plots contain a region of interest area (ROA) that focuses on the area 
after the arch which is the descending aorta.  The scale of the velocity magnitude is from 0 to 0.9 
m/s with the color scale ranging from blue being 0 m/s and red being 0.9 m/s.  As shown in 
Figure 4.14, the velocity magnitude distribution/profile appears to be uneven about the centerline 
of the aorta.  This profile continues further down from the ROA site.  However when 
approaching the arch area near the aortic valve, the largest magnitude of velocity occurs near the 
centerline.  The largest magnitude of velocity occurs near the outer wall of the aorta near the 
descending aorta region.  Although there are areas of high velocity approaching the wall, the no-
slip condition is captured at the outer wall.  In Figure 4.12 highlights this phenomenon more 
clearly. 
Figure 4.15 contains a plot of the velocity profile at one location of the ROA site at 
different time intervals (T).  The velocity profiles shown in Figure 4.15 highlight the change in 
velocity as a function of time.  The profiles confirm the uneven distribution of velocity across the 
diameter of the ROA site.  At time T= 3s, the velocity reaches systole which is the peak velocity 
in the cardiac cycle.  The maximum velocity at systole appears to be around 0.5 m/s.  However 
when looking at the velocity contours, the contour highlights sections where the velocity reaches 
a maximum around 0.9 m/s.  The velocity profiles were extracted midway of the ROA site.  
From the velocity profiles and the velocity contours, a general conclusion can be made that that 
the velocity profile is not constant along the axial direction of the aorta.  This in part could be 
due to the curves and bends in the aorta that produces vortices and unsteadiness in the trajectory 
of the flow.  This could also be due to the dampening/fluctuations of harmonic from the 


















 (a)  
 
(b) 
Figure 4.15. Plot of velocity profile for: (a) different time steps and (b) profile and velocity 




The velocity contours are also useful because it provides information about the transport of 
blood.  The artery itself contains a lining of cells in the interior core in which the blood is in 
contact with.  The blood feeds nutrients to these cells.  It has been hypothesized that the wall 
shear stress promotes or deters cell growth and maintenance.  In actuality, the transport of blood 
to the artery wall provides the necessary nutrients to the cell lining.  From the contour plots, one 
can see that high levels of transport take place near the wall.  Figure 4.16 provides a plot of 
diameter vs. wall shear stress at systole (time T=3s).  The wall shear stress was derived from the 







          Eqn. 4.10 
The derivative of the velocity distribution was taken and multiplied by the viscosity of the 
working fluid and fitted using the diameter of the pipe.   A plot of this is shown below in Figure 
4.16. 
 




As shown in Figure 4.16, the minimum wall shear takes place at the centerline which indicates 
that the gradient is near zero at the centerline.  The highest wall shear takes place at the wall.  
The normal range of wall shear stress in the arteries ranges from 1-12 Pa.  The highest wall shear 
stress occurs during systole and falls within the range of 1-12 Pa.  The highest wall shear 
observed is around 11.8 Pa.  Information such as this is useful for predicting cell death, rupture, 
and buildup of plaque.  Compliance is another important parameter in the analysis of 
cardiovascular disease. 
Compliance in the aorta is thought to have a strong role in the progression of 
cardiovascular diseases.  In the present study, compliance is not calculated directly.  However 
the change in diameter is used determine the overall compliant nature of the arterial wall.  Figure 
4.17 provides a plot of the diameter of the aorta as a function of time during the rest state cardiac 
cycle.  The relaxed diameter (diameter of the aorta with the pump off) is 32 mm.  The maximum 
diameter 34 mm (systole) is and the minimum diameter is 32.9 mm (diastole).  The maximum 
change is diameter is 2 mm and the minimum diameter change is 0.9 mm.  The percent 













         Eqn. 4.11 
Using equation 4.11, the maximum percent change in diameter is 6% and the minimum is 2.7%.  
The change in diameter in this case is important because it provides insight on the possibility of 
aneurysm/rupture.  In most cases, the aorta ruptures after severe hardening but can also rupture 
during cyclic expansion.  Also it is evident that the change in diameter promotes additional 




used for prediction of flow patterns and profiles.  Most CFD studies use rigid models that don‟t 
capture the full effect of fluid structure interaction effects. 
 
 
Figure 4.17. Diameter vs. Time for the aorta during rest state cycle. 
 
4.4 Drug Eluting Stent Drug Mass Concentration Studies 
In the present study, a drug eluting stent (DES) diffusion time analysis study was 
conducted.  The DES simulations for the present study compare the intravascular drug delivery 
from a drug coated stent with its coating diffused into the arterial wall.  The model developed for 
drug delivery, the drug internalization rate, interstitial fluid flow, and strut embedment are 
investigated for their impact on the drug transport and distribution.  In the model simulations, a 
half strut-embedment is considered and the internalization rate and the interstitial fluid flow 




examining the impact of individual model factors.  As mentioned previously, the plasma flow 
which is normal to the lumen flow is set to 1E-8m/s.  The no-slip condition is specified at the 





Figure 4.18. Velocity contour of plasma flow into the artery wall. 
 
The simulation results are reported for unbound drug release profiles in the arterial wall.  
Specifically, the average drug concentration in the arterial wall is defined as the spatial average 
of the drug.  The three means of characterizing the drug delivery process are consistent with 
other modeling works, while contributing to the possibility for potential comparison with future 
experimental measurements.  In the simulation comparison, the total drug release is achieved in 




condition is also applied to the left and right boundaries based on symmetry, and at the coating-
strut interface.  At the coating-arterial wall interface, an equal flux constraint and equal 
concentration partitioning are applied.  For the initial conditions the drug is initially uniformly 
distributed into the arterial wall as shown in Figure 4.19a and Figure 4.19b. 
In observing drug release profiles, from the time of deployment up until the first five days 
when the degradation and erosion appear to be minor.  In the simulation comparison, the drug 
concentration is around 95% on day 115.  Corresponding to the difference in the release profiles, 
the average drug concentrations in the arterial wall starts off with similar levels for the released 
drug.  The drug concentrations gradients appear very early in the case around day five.  The drug 
level increases as a result of accelerated drug release by degradation and erosion in the coating.  
The fast increase in drug concentration is contributed by the fast drug clearance rate at the 
interface.  In each case, the trends of concentration evolution for the free drug are highly 
identical, as a result of the fast reversible binding process in comparison to drug diffusion. 
The drug distribution is close to uniform in the circumferential direction (x-direction) as 
shown in Figure 4.19 c, d, and e, whereas in the transmural (z-direction) direction a gradient is 
clearly observed closer to the perivascular interface.  Upon close inspection, minor asymmetries 
in the concentration profiles can be observed in Figure 4.19 e, f, g, and h.  This is not numerical 
error but occurs because of slight differences in the volume of tissue proximal and distal to the 
stent after deployment.  The stent was centered with respect to the axial direction before 
deployment.  This symmetry was broken during deployment because of stent foreshortening.  
While these asymmetries are noticeable, they are not significant enough to affect the 
interpretation of the parametric studies.  It is even more visible in Figure 4.20.  A measurement 




concentration of the wall.  The better uniformity in the circumferential direction is expected with 
the aniostopic drug diffusivity which results in fast drug diffusion in the circumferential 
direction.  The observed arterial drug distribution patterns appear to have nonlinear trends in 













Figure 4.19. (a) 5 days, (b) 15 days, (c) 25 days, (d) 35 days, (e) 45 days, (f) 55 days, (g) 65 days, and 
(h) 115 days. 
Mass Concentration 





Figure 4.20. Drug concentration vs. distance for DES analysis. 
 
Figure 4.20 reveal how the deposition patterns tend to follow the pattern of the stent struts and 
how the drug is able to penetrate deep into the vessel wall.  Figure 4.20 also shows a trend that 
shows that the concentration profile from strut to strut becomes more steep and linear as time 
progresses.  The profile becomes more linear near day 45.  For this particular case, the drug used  
diffuses completely around 3.5 months.  A drug release profile study was also conducted on the 
entire cardiovascular system using CFD. 
 
4.5 Evaluation of the Effect of Patient-Specific Geometry on Hemodynamic Flow 
In the present work, CFD analyses were performed on a simplified carotid bifurcation 
arterial geometry and two patient-specific carotid bifurcation arterial geometries.  The 
geometries are discretized and used as computational domains.  For blood flow simulations, the 




incompressible, and isotropic are implemented.  By these assumptions, blood can be modeled by 
the incompressible Navier-Stokes equations with blood density specified as 1060 kg/m
3
 and the 
corresponding dynamic viscosity as 0.0035 kg/m s.  The commercial software Gambit
TM 
was 
used for geometric meshing and FLUENT
TM 
was used to solve the Navier-Stokes equations in 
the finite volume formulation.  Equation 4.12 is used to solve the fluid flow equations in the 
finite volume form.   
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       Eqn. 4.12 
Two CFD analyses were conducted.  The first analysis was conducted with a simplified 
sinusoidal velocity waveform which simulates a rest-state cycle.  The rest-state cycle is 
implemented as a boundary condition at the inlet of the CCA branch of each arterial geometry.  
The first analysis compares the magnitude of hemodynamic parameters in a simplified arterial 
geometry and two patient-specific geometries and compares the efficacy of modeling simplified 
geometries as opposed to patient-specific geometries.  The second analysis implements two 
patient-specific velocity waveforms, one at rest-state and exercise and compares the magnitudes 
of hemodynamic parameters at both rest state and exercise.  The second analysis also compares 
the efficacy of modeling patient-specific geometries over simplified geometries.  For both 
analyses, the ICA and ECA outlets were modeled as pressure outlets at 12 kPa (90mmHg).  A 
grid independent study was conducted prior to assessing the hemodynamic results.  Grid meshing 
levels were performed at three levels: coarse (104,406), coarse (143,948) and medium (233,045) 
and it was determined when evaluating wall shear stress and pressure that the CFD results were 
no longer depending on the size of the mesh at 233,046 cells.  Table 4.3 show the grid 






In comparison of the velocity at the ICA for geometric models, a 0.21% difference in 
velocity was observed for a grid independence study.  For numerical solutions, the velocity 
coupling solving technique was implemented.  The WSS vectors are predicted on fluid domain 
surfaces that represent the interface boundary between the fluid and the neighboring tissue.  For 
analyses, the WSS are calculated using Eqn 4.13.  Velocity is monitored at the CCA, ECA, and 
ICA and vorticity is calculated at the sinus bulb.  CTA images of stenosed carotid bifurcations 
were taken from a 50 and 66 year old male and were processed in Solidworks.  Figure 4.21 
presents a schematic diagram of the Solidworks processing methodology.  The parametric data of 
the patient-specific carotid artery geometries (CA-1) and (CA-2) is provided in Table 4.3. 
Simulations and analyses were performed for three geometries, the simplified carotid bifurcation 
arterial geometry (SA-1) and two patient-specific carotid bifurcation arterial geometries (CA-1) 
and (CA-2).  For the second analysis, SA-1 geometry is replaced with a second simplified 
geometry that resembles a patient-specific geometry.  The simplified geometry used in the 
second analysis contains the same diameter for the CCA, ICA, and ECA as in patient-specific 
geometry (CA-1).  The difference however is that the diameters are constant on all branches as 





















Age 66 year(s) 60 year(s) 
Sex Male Male 
Side Left Left 
Basis of disease Atherosclerosis Atherosclerosis 
Direct cause of death IMA Aneurysm 
Diameter of CCA 7.475 mm 7.725 mm 
Diameter of ECA 5.35 mm 5.0 mm 
Diameter of ICA 8.0 mm 6.075 mm 
Diameter of Carotid Sinus 5.7 mm 7.6 mm 
Branch angle between CCA 
and ICA 
45 degrees 29.5 degrees 
Branch angle between CCA 
and ECA 





Figure 4.21. (a) CTA scan point cloud image, (b) 3D spline surface generation, (c) lofted and 
boundary base solid part model of the carotid bifurcation, (d) meshed post-
processed carotid artery geometry. 
 
Figure 4.22 shows a CAD drawing of both arterial models.  The location of the sinus bulb 
was monitored for calculating WSS and vorticity as a function of time.  Previous studies have 
suggested that vortictity measurements are predictors of flow disturbances which in turn 
produces high levels of shear and promotes the onset of shear licensing and or rupture of the 




arterial geometry and patient-specific arterial geometries at any point in time.  Figure 4.23 shows 
the velocity waveform monitored at the ICA outflow of the three geometries at time 0s to 3s.  At 
the beginning of the cycle, the blood flow rate starts increasing and reaches a maximum level 
around 0.45s and then decreases to the lowest level at 1.3s.  Figures 4.23 present a plot of the 
vorticity vs. time for the SA-1, CA-1, and CA-2 geometries. 
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        Figure 4.23. Plot of sinus vorticity vs. time for the CA-2 patient-specific geometry and 




Figure 4.24 shows the axial velocity contours of the sinus at time 0.5s (systole), and Figure 4.25 


























The negative velocity indicates flow reversal zones.  As shown in Figures 4.24 and 4.25, the 
maximum flow reversal is observed in the patient-specific geometry models.  For the patient-
specific geometries, it was also observed that the axial velocity is the highest at the region 
upstream of the ICA and downstream of the sinus near the CCA.  Regions of flow reversal 
formed near the sinus wall are due to the rapid changes in the flow rate, flow viscosity and the 
curvature of the sinus.  Within these zones, blood flows in the direction opposite to the mean 
flow increasing the probability of plaque deposition. 
For the patient-specific geometries, the velocity gradients near the stenosis are much 
higher than those near the sinus.  The velocity at the sinus becomes negative and indicates flow 
reversal and very low WSS.  WSS is an important factor in the progression and initiation of 
atherosclerosis.  For the simplified geometry, there is a small region of velocity increase at the 
stenosis, and very little flow downstream of the stenosis to the ICA outlet.  The major increase of 
velocity in the simplified geometry is experienced in the ECA branch of the artery.  Figure 4.24 
shows the WSS contour for systole (peak velocity) for the simplified arterial model and patient-
specific geometries.  Regions with WSS less than 0.4 Pa are susceptible to atherosclerosis. In the 
wall shear stress contours provided in Figure 4.24, it is shown that the maximum WSS 
experienced is 16.3 Pa.  The maximum WSS is shown at the ICA stenosed region of SA-1 and at 
the stenosis and bifurcating region of CA-1. 
A general conclusion from these WSS patterns is that the sinus bulb is the most 
atheroprone site where higher values of WSS appear at the bifurcation apex and final ends of the 
ECA and ICA, which have a smaller diameter.  There is a stagnation point at the apex because 

















relatively high).  The stagnation point is the place of plaque buildup.  Another point is that, in 
general, realistic geometries have higher values of WSS and the atheroprone site in the sinus 
bulb is smaller.  When considering WSS, the magnitude of the wall shear is a function of the 
geometry of the arterial vessel.  This works proves that when studying hemodynamics of the 
arterial vasculature, specifically the carotid bifurcation artery for diagnostic purposes, it is 
important to have patient-specific parametric data for the carotid bifurcation vessel to be 
analyzed.  In addition to geometry comparisons in the efforts of comparing hemodynamic 
parametric magnitudes, a comparison was also made in studying the effect of patient-specific 
waveform on hemodynamic parameters. 
Pulsatile blood flow during rest-state and exercise were simulated for the three carotid 
bifurcation arterial geometries, the simplified carotid bifurcation arterial geometry and two 
patient-specific arterial geometries (CA-1) and (CA-2).  As mentioned earlier, SA-1 is replaced 
with a more realistic geometry.  The new SA-1 contains a constant diameter along the centerline 
of each branch of the artery.  From this point, the simplified carotid artery will be referred to as 
artery “S”, the patient specific artery CA-1 will be referred to as artery “A”, and CA-2 as artery 
“B”.  The volumetric flow rate waveforms used in the present study are aortic artery blood flow 
rate waveforms during rest-state and exercise.  For each case evaluation, fully-developed 
velocity boundary conditions were imposed at the inlet during steady-state calculations and were 
iterated until the solution converged and a feasible hemodynamic solution was obtained.  After 
the steady-state calculation converged and feasible hemodynamic solutions were observed, the 
solver was then switched to transient solver for rest-state and exercise calculations.  Volumetric 




patient-specific geometries for two cardiac cycles.  Figure 4.27 presents the volumetric flow 










As shown in Figure 4.27a during the rest cycle, at the beginning of the cycle, the blood 
volumetric flow rate accelerates and reaches a maximum level around 11.2 ml/s and then 
decreases and to 1.7 ml/s and then accelerates to 4.2 ml/s decelerates again and remains constant 
at 3.8 ml/s until the cycles starts over again at 1s.  When comparing hemodynamics during the 
rest-state cycle, for Carotid Artery A, the ICA branch which supplies blood to the brain reaches a 
maximum blood flow rate of 2 ml/s while the ECA reaches a maximum flow rate of 7.8 ml/s.  
Similarly, for Carotid Artery B, the ICA branch reaches a maximum blood flow rate of 2.2 ml/s 
while the ECA reaches a maximum flow rate of 9.8 ml/s.  As shown in Figure 4.27b, during 
exercise, for Carotid Artery A, the ICA branch which supplies blood to the brain reaches a 
maximum blood flow rate of 3 ml/s while the ECA reaches a maximum flow rate of 11.8 ml/s.  
Correspondingly, for Carotid Artery B, the ICA branch reaches a maximum blood flow rate of 4 
ml/s while the ECA reaches a maximum flow rate of 14.8 ml/s.  When analyzing volumetric flow 
rate for rest-state and exercise, the volumetric flow rate on all outlets for all three arteries 
increases by a magnitude of 1.5 when switching from rest-state to exercise. 
Figure 4.28 presents the average weighted WSS contours during rest-state and exercise.  
The normal range of WSS in the arteries of a healthy human being is 7-12 Pa during normal 
activity.  The WSS contour snapshots are taken at the highest volumetric flow peak during the 
cardiac cycle (systole).  As shown in Figure 4.28, the simplified carotid bifurcation arterial 
geometry, denoted at the top of the snapshot by the bold red “s” in a square bracket, appears to 
have 0 WSS on the ICA branch during systole of the rest-state cycle.  However, during exercise, 
the average weighted WSS on the ICA branch increases to 0.65 Pa.  The highest WSS occurs on 




weighted WSS on the CCA and ICA is 1.95 Pa, while during exercise on the ECA branch the 
WSS increases to 9.75 Pa.   
 
 
Figure 4.28. WSS contours at systole during: (a) rest-state and exercise. 
 
However for the patient-specific carotid bifurcation arterial geometry A, there is 0 WSS on the 
sinus bulb during rest-state and exercise.  The value of 0 WSS on the sinus bulb indicates that 
there is no mass transport of blood on the sinus bulb region which also indicates that the sinus 
bulb will experience endothelial cell death and rupture if there is no transport of blood in that 
region.  From Figure 4.28, the highest WSS that occurs in the patient-specific geometry A during 




specific geometry B, the sinus bulb experiences a WSS magnitude of 3.32 Pa during rest and an 









However as shown in Figure 4.29, the ECA branch of Carotid B reaches a maximum average 
weighted WSS of 4 Pa during exercise, while the ICA reaches a maximum of 9 Pa.  Figure 4.29 
also shows that Geometry A experiences the highest peak of WSS of 17 Pa on the ECA branch.   
This is due to the highest magnitude of flow taking place on the ECA branch.  The cross-
sectional area of the ICA branch on geometry A is much smaller than the ECA, and due to 
continuity, the flow is accelerated on the ECA branch which has a larger cross-sectional area.  
Figure 4.30 presents the average weighted NS contours during rest-state and exercise. 
 





The NS contour snapshots are also taken at systole.  As shown in Figure 4.30, the simplified 
carotid bifurcation arterial geometry, experiences an equalized balance of NS on all branches of 
the artery during rest-state.  The average weighted NS is 0.72 Pa on the CCA, ECA, and ICA. 
However on the bifurcation region near the ECA, a small region experiences a slightly high NS 
of 1.61 Pa.  However, during exercise, the average weighted NS increases from the bifurcation 
region throughout the ECA on the simplified geometry during exercise.  The same trend occurs 
on Geometry B; however the magnitude on the ICA and CCA is 2.5 Pa with a small region on 
the sinus of –1.95 Pa.  The negative sign indicates a compressive force, whereas the positive NS 
values indicate tensile.  The magnitude of NS on the ECA has a concentrated region of NS of 
around 8.74 Pa and diminished to 4.28 Pa throughout the ECA.  The same can be found true on 
Geometry B, the magnitude.  The average NS on all branches of Geometry B is 2.5 with a small 
region on the ICA branch experiencing a compressive force of -1.95 Pa.  The NS forces are 
important in analyzing the forces that may produce rupture in atheroprone areas or in a more 
generalized sense, areas that are experiencing endothelial cell death and thinning of the vessel 
lining. 
As shown in Figure 4.31, vorticity in the arteries has the same trend as WSS. For the 
simplified case minimum vorticity (7.49 s
-1
) takes place on the ICA, whereas on the CCA and 
ICA branch a magnitude of 1030 s
-1
 is experienced.  For Geometry B, the least amount of 
vorticity is seen on the sinus bulb region whereas the highest magnitude takes place on the ECA 
branch.  The least amount of vorticity occurring on the sinus bulb region is due to the lack of 
mass transport on the wall of the sinus.  The maximum vorticity is due to continuity, the 
restriction of flow taking place on the ICA branch causes an acceleration of blood flow on the 




the CCA branch throughout the ECA; however the highest magnitude of voracity is experience 
on the ICA branch.  WSS, NS, and vorticity are vital measurements for assessing hemodynamic 
factors. In the present study, these three measures have been used to verify the role of age,  
 
Figure 4.31. Vorticity contours at systole during: (a) rest-state and exercise. 
 
gender, and geometry on hemodynamic flow patterns.  The simplified geometry in the present 
study has proven to provide an exaggeration of hemodynamic parameters during analyses.  The 
simplification of arterial vessel geometry yields hemodynamic results that cannot be substituted 
and relied on for real life measurements for male and female patients.  For instance, for all cases 




branch which indicates no mass transport and for NS, equalized magnitudes of NS measurements 
on all branches with the exception of the bifurcation region.  Geometry A and B yields 
meaningful results in the sense that the hemodynamic results are different in the case of age, 
gender, and arterial vessel geometry.  The hemodynamic trends are different in the case of 
evaluating patient-specific geometry, thus confirming the effect of age, gender, and geometry on 
hemodynamics.  Also the case of evaluating hemodynamics during rest-state and exercise has 
provided meaningful results in the sense that the magnitude of WSS during exercise provides a 
measure of the risk of WSS licensing of red blood cells, and NS provides a magnitude range for 
the risk of vessel rupture. 
 
4.6 Evaluation of the Effect of Stent Design on Hemodynamic Flow  
In the present study, the hemodynamic features of a simplified vs. patient-specific stented 
arteries are compared.  In addition to simplified and patient-specific stented arteries, three 
different stent designs are assessed.  Differences in WSS, normal (radial) stresses, and vorticity 
(de-mixing) are reported which confirms the effect of stent design, specifically strut positioning 
bridge pattern design on hemodynamics.  Eqn. 4.13 is used to calculate the normal stresses.  
Physiological WSS in an artery is normally within a range from 1 Pa to 7 Pa (Malek 1999).  
However, WSS that exceed this range and occur at localizes sites can influence dislodging and/or 
migration of the stent.  Figure 4.32 present the WSS contour plots of the simplified stented cores 
for stent designs A, B, and C.  The highest WSS values were found to occur over the center of 














               
Figure 4.32. Wall shear stress contour for stent designs A,B, and C. 
Also Figure 4.32 shows the regions of low WSS before and after each strut.  For the simplified 
stented core and patient-specific stented core CFD analyses, WSS follows a trend for all stents 
except for regions between the strut and bridge, as shown in Figure 4.32.  For stent designs A 
and C, a larger area of arterial tissue is exposed to relatively low WSS (light blue area in Figure 






wall area within the first unit cell experiences a relatively high WSS compared to the area around 
the stent struts.  For Stent Designs A and C, areas of low WSS occur at transitions between the 
core and stent and were most pronounced where the strut orientation was orthogonal to the 
direction of blood flow.  For all three stents, WSS had a high value proximal to the stent struts 
and a relatively lower value in the area occupied or exposed to neighboring arterial wall tissue.  
Figure 4.33a shows the point averaged normalized WSS patterns for all stents averaged 
over the entire stent wall core impression for the simplified stented cores and the patient-specific 
arterial stented cores.  Figures 4.33a and 4.33b show the scaled WSS and radial stress results of 
the incoming fluid.  The stresses are scaled with the dynamic pressure “ρV
2
 ”and the cycle time 
is scaled with the total time, t=3 sec.  As shown in Figure 4.33a, the maximum normalized WSS 
for all stents occur at the point of maximum inlet velocity (systole) and the minimum normalized 
WSS occurs at the minimum inlet velocity (diastole).  When comparing the normalized WSS 
results for the simplified arterial stented core results compared to the patient-specific stented core 
results, the percent difference of the point averaged normalized WSS for Stent Design A is 
44.7%, 44.4% for Stent Design B, 55.8% for Stent Design C, and 25.65% for the Simplified 
Stent Design. 
Maximum WSS within the stented region for all stent designs are localized within the 
curved regions of the struts.  Figure 4.33b shows the normalized point averaged radial stress 
trend for all stents averaged over the entire stent wall impression for the simplified stented cores 
and the patient-specific arterial stented cores.  When comparing the normalized radial stress 
results for the patient-specific arterial stented cores compared to the simplified arterial stented 




plots of the distributions of normalized WSS as a function of normalized strut distance within the 
unit cell of each stent design.   
 
 
Figure 4.33. Plot of: (a) normalized wall shear stress vs. normalized time and (b) normalized 
radial stress vs. normalized time. 
 
The distance is scaled with the total distance from strut to strut (x*=x/L).  From Figure 
4.34a and 4.34b, the trend of WSS within the area where the tissue is exposed to the blood has a 




large area of tissue exposure which minimizes flow disturbance and also minimizes flow 
resistance.  In Figure 4.34c, the maximum WSS occurs in the unit cell area where the tissue is 
exposed to blood flow which is due to the minimum area that exists between struts for stent 
design C.  Also stent design C has more struts compared to stent designs A and B, which 
influence flow disturbance and WSS.  A general conclusion that can be drawn from these 
analyses is that large arterial tissue exposure within the stent unit cell experiences a lower WSS 
compared to stents with small arterial tissue exposure.   
 
 
Figure 4.34. Plot of normalized wall shear stress vs. normalized strut distance for (a) stent design 
A and simplified stented core, (b) stent design B and simplified stented core, and 





The flow distributions and WSS in larger arterial tissue exposure minimize due to the 
absence of stent struts.  Figure 4.35 present plots of distributions of normalized radial stress as a 
function of normalized strut distance within the unit cell of each stent design.  The trend of 
increasing stress with smaller arterial tissue exposure is observed in the results presented in 
Figure 4.35.  
 
 
Figure 4.35. Plot of normalized radial stress vs. normalized strut distance for: (a) stent design A, 







When comparing the magnitudes of WSS and radial stress, the radial stresses that occur in both 
the simplified stent arterial cores and patient-specific arterial stented cores are much smaller 
compared to WSS and can be neglected.  As shown previously in Figures 4.34 and 4.35, the 
presence of a stent inside the arterial vessel gives rise to flow resistance and flow recirculation 
(vorticity).  Vorticity is defined as the spin or rotation of a fluid.  Vorticity is an important 
parameter in accessing hemodynamic factors because the magnitude of vorticity influences the 
separation of blood constituents.  Vorticity can be defined as the magnitude of de-mixing as it 
pertains to hemodynamics.  Blood is a heterogeneous mixture of various substances and the 
magnitude of vorticity in stented arteries influences flow alteration and may cause acute 
pathobiological responses.  As mentioned previously, vorticity has been a major predictor of wall 
shear disturbance and vessel rupture. 
Figure 4.36 shows plots of the point averaged axial vorticity patterns for all stents 
averaged over the entire stent wall core impression for the simplified stented cores and the 
patient-specific arterial stented cores for the entire cardiac cycle.  Figure 4.36a shows that the 
highest magnitude of flow reversal (de-mixing) exists in Stent Design C, followed by Stent 
Design A, the Simplified Stent Design, and Stent Design B.  Figure 4.36b shows that the highest 
magnitude of flow reversal exists in Stent Design A, followed by the Simplified Stent Design, 
Stent Design C, and lastly Stent Design B.  Figures 4.36a and 4.36b, show that the hemodynamic 
behavior of the flow of a stented vessel is not only a function of the stent geometry, but the 







Figure 4.36. Plot of axial vorticity vs. flow time. 
 
Figure 4.37 shows the magnitude of recirculation that occurs between the struts of all stented 
cores.  The magnitude of recirculation varies with distance from strut to strut.  For example, in 
Figure 4.37a, Stent Design A has a vorticity magnitude of 650 s
-1
 which then changes direction 
and magnitude to 620 s
-1
 and then minimizes to 198 s
-1
 before stabilizing to a vorticity magnitude 
around 90 s
-1
.  Recirculation zones in the cross-flow direction are observed for all stent designs 
close to the arterial wall.  Recirculating flow may be caused by the bridge connectors that 
protrude into the space between the struts.  It is important to note that the magnitude of vorticity 
is different for each stent design.  Also as shown in Figure 4.37, the magnitude of vorticity varies 
with the geometry of the arterial core upstream of the stented region entrance.  WSS and radial 
stresses is a function of stent design, and vorticity is also a function of both stent design and the 














4.7 Digital Cardiovascular Phantom Hemodynamic Results 
 In the present study a simple analysis was conducted to analyze the levels of wall shear 
stress and normal stress that are present in the arteries of the full digital cardiovascular system.  
Thus far, all of the hemodynamic parameters analyzed such as normal stress, wall shear stress, 
and vorticity in the arteries via CFD have been analyzed in systems whereby the artery analyzed 
is a single unit (an artery that is not connected with its neighboring constituent arteries).  The 
present study addresses the magnitude of stresses found in the arterial system during a normal 
cardiac cycle.  The digital cardiovascular system is the same model that was used earlier in the 
dye concentration analyses.  The analysis discussed here consists of a rest state cycle analysis 
and static posture study. 
Figure 4.38 present the wall shear stress contours for the digital cardiovascular phantom.  
The contours present the wall shear magnitudes at different times during the cardiac cycle.  
Figure 4.38a present the wall shear stress contour at diastole and Figure 4.38b present the wall 
shear stress contour at systole.  The contours are broken into sections due to regions of varying 
wall shear stress in the digital cardiovascular system.  The magnitude of the wall shear stress is 
higher in the mid-section of the phantom (aortic section) as appose to the upper level (cerebral).  
The same is true for normal stress.  As mentioned earlier in the preceding sections, the range of 



























Figure 4.38. Wall shear stress contours during (a) diastole and (b) systole. 
From Figure 4.33 the wall shear stress magnitude scale ranges from 0 to 0.7 Pa.  The 
cardiovascular phantom represents a healthy male.  From Figure 4.38, the highest wall shear 




highest wall shear stress during systole is in the CCA and the femoral section at 0.7 Pa.  Also 
observed in the Figure 4.38b is that the highest wall shear stress is observed in sections where 













Figure 4.39. Wall shear stress contour for the coronary arteries. 
Figure 4.39 presents the wall shear stress contours for the coronary arteries which are attached to 
the aortic valve section.  The scale of the wall shear stress for the coronary arteries ranges from 0 
to 2 Pa.  Similar to the wall shear stress in the neighboring arteries, the highest wall shear stress 
occurs around curves and bends.  The highest wall shear observed in the coronary arteries is 2 Pa 
which is at systole.  The reason for the highest wall shear being present in the coronary is 
because the coronary arteries have a much smaller diameter than the aorta.  The Venturi effect 




nature of acceleration in flow due to a reduction in area.  Continuity states that mass must be 
conserved regardless of the increase or decrease in area.  The highest wall shear indicated 
regions where there is accelerated transport of blood.  Previous studies have indicated that wall 
shear stress promotes cell growth.  It is hypothesized in the present study that the transport of 
blood and nutrients promotes cell growth and that wall shear stress is a mere indication of 
transport.  The most significant take away is that in a normal situation for rest state cycle is that 
the range of wall shear stress is from 0 to 2 Pa and that the highest magnitude of wall shear is 
present in sections where there are curves, bends, and branching into constituent arteries. 
Figure 4.40 present the normal stress contours for the digital cardiovascular phantom.  
The contours present the normal stress magnitudes at different times during the cardiac cycle.  
Figure 4.40a present the normal stress contour at diastole and Figure 4.35b present the normal 
stress contour at systole.  Similar to Figure 4.40, the contours are broken into sections due to 
regions of varying normal stress in the digital cardiovascular system.  The magnitude of the 
normal stress is higher in the mid-section of the phantom (aortic section) as appose to the upper 
level (cerebral).  From Figure 4.40 the normal stress magnitude scale ranges from -0.1 to 0.275 
Pa.  From Figure 4.40, the highest normal stress during diastole at rest state cycle is observed in 
femoral section around 0.0253 Pa.  The highest normal stress during systole is in the CCA and 
the femoral section at 0.275 Pa.  The normal stress is useful because it provides insight on the 
level of forces normal to the direction of flow is present.  High normal forces can promote 
restenosis, penetration/rupture, and dislodging/movement of medical implants.  Figure 4.41 
presents the normal stress contours for the coronary arteries.  The scale of the normal stress for 





























Similar to the normal stress in the neighboring arteries, the highest wall shear stress occurs 
around curves and bends.  The highest normal stress observed in the coronary arteries is 1.40 Pa 

















 (a) (b) 
Figure 4.41. Normal stress contours for the coronary arteries during (a) diastole and (b) systole. 
 
Similar to the wall shear contours, the highest stress is observed in regions where there are 
curves and bends.  Future studies are needed to confirm the magnitude of stress for healthy and 





5 CHAPTER 5 
Discussion and Future Research 
The ultimate goal of the present study was to aid in the development of tools to assist in 
the treatment of cardiovascular disease and atherosclerosis.  In the present study a full 
cardiovascular experimental phantom and digital phantom (CFD model) was fabricated to study: 
(1) the effects of local hemodynamics on global hemodynamics, (2) the effects of transition from 
bed-rest to upright position, and (3) transport of dye (drug delivery) in the arterial system.  
Computational three dimensional (3-D) models of drug eluting stents implanted into the arterial 
wall were studied in addition to patient-specific arterial hemodynamic models and stents design 
flow studies.  In the case of the drug eluting stent studies, the main conclusion is that using the 
diffusivity for the drug analyzed in the present study, the time that it takes for the drug to diffuse 
through the entire wall for the implanted stent is approximately 3.5 months.  Future studies will 
involve implementing internalized reversible binding of the drug to study the effect of unbound 
on bound drug diffusion through the artery wall.  Future studies will also involve implementing 
porosity parametric studies on stent design to evaluate the effect of stent design on drug 
diffusion.  For postural change studies, future studies will involve implementing coding to 
simulate baro-regulation to incorporate the full effect of orthostatic pressure changes and 
systematic responses. 
For arterial CFD studies, patient-specific CA models were generated from computed 
tomography angiography (CTA) scans and modeled for CFD.  The simulated flow profiles in the 
patient-specific geometries were compared against a simplified carotid bifurcation geometry to 
evaluate the efficacy of modeling patient-specific geometries against an alternate simplified 




patient-specific and simplified velocity waveforms.  The main conclusion in this work is that 
dynamic behaviors of blood through the patient-specific carotid bifurcation arterial geometries 
based on numerical approaches showed differences when compared to a simplified carotid artery 
bifurcation geometry.  For the patient-specific geometries, the velocity gradients near the 
stenosis were much higher than those near the sinus.  Flow reversal and low WSS was observed 
in the sinus region of the patient-specific models.  Also, for the simplified geometry, there was a 
small region of velocity increase at the stenosis, and very little flow downstream of the stenosis 
to the ICA outlet.  The major increase of velocity in the simplified geometry was experienced in 
the ECA branch of the artery, while in the patient-specific geometries, the reverse is true.  The 
present study has proven that using simplified arterial geometries results in an exaggeration of 
hemodynamic parameters thus confirming the effect of age, gender, and arterial vessel geometry 
on hemodynamics. 
Future studies will incorporate the moving boundary of the arterial wall, instead of using 
rigid wall boundary conditions.  A future study consisting of a broad statistical study on the 
effect of patient-specific arterial geometry on hemodynamic flow will be conducted.  For dye 
concentration studies using the cardiovascular phantom, a more accurate study will be conducted 
using photo-diodes to measure the dye concentration as function of time non-invasively.  In the 
case of evaluating the effect of stent design on hemodynamic flow, future studies will also 
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